Global Digital Solutions (GDSI) S-1/A 3 Aug 23 IPO registration (amended) Financial data

Cover

Cover	3 Months Ended
	Mar. 31, 2023
Cover [Abstract]
Document Type	S-1/A
Amendment Flag	true
Amendment Description	Amendment No. 1
Entity Registrant Name	Global Digital Solutions, Inc.
Entity Central Index Key	0001011662
Entity Tax Identification Number	22-3392051
Entity Incorporation, State or Country Code	NJ
Entity Address, Address Line One	777 South Flagler Drive
Entity Address, City or Town	West Palm Beach
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33401
City Area Code	561
Local Phone Number	515-6163
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Current assets
Cash	$ 1,585	$ 1,043	$ 98,800
Total current assets	1,585	1,043	98,800
Other Assets
Due from related entity, (Note 9)			80,914
Prepaid Expense, (Note 9)			22,500
Equipment net of accumulated depreciation of $ 17,773			33,009
Software Development costs			64,547
Total other assets			200,970
Total assets	1,585	1,043	299,770
Current liabilities
Accounts payable	363,403	363,402	361,813
Accrued expenses	1,993,038	2,028,801	1,481,910
Due to Officer (Note 9)	3,281	3,281	50,000
Due to related entity, (Note 9)	8,198	50,233
Financed insurance policy	11,187	11,187	11,187
Derivative liability	2,019,000	3,421,000	809,000
Warrant Liability	748,000	1,599,000	606,000
Convertible notes payable, net of discount of $246,470 and $652,178, respectively	3,460,050	3,992,396	3,310,662
Notes Payable	4,607,125	4,607,125	4,627,000
Total Current Liabilities	13,213,282	16,076,425	11,257,572
Notes payable			103,125
Total Liabilities		16,076,425	11,360,697
Stockholders’ deficit
Preferred stock, $0.001 par value, 35,000,000 shares authorized, 1,000,000 shares issued and outstanding at December 31, 2022, and 2021 respectively	1,000	1,000	1,000
Common stock, $0.001 par value, 2,000,000,000 shares authorized, 800,543,896 shares and 737,263,858 issued and outstanding at December 31, 2022, and 2021, respectively	901,502	800,544	737,264
Additional paid-in capital	40,406,740	38,233,710	37,370,384
Shares Issuable			180,000
Accumulated deficit	(54,520,939)	(55,110,636)	(49,349,575)
Total stockholders’ deficit	(13,211,697)	(16,075,382)	(11,060,927)
Total liabilities and stockholders’ deficit	$ 1,585	$ 1,043	$ 299,770

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Discount	$ 291,584	$ 246,470	$ 652,178
Preferred stock, par value	$ 0.001	$ 0.001	$ 0.001
Preferred stock, shares authorized	35,000,000	35,000,000	35,000,000
Preferred stock, shares issued	1,000,000	1,000,000	1,000,000
Preferred stock, shares outstanding	1,000,000	1,000,000	1,000,000
Common stock, par value	$ 0.001	$ 0.001	$ 0.001
Common stock, shares authorized	2,000,000,000	2,000,000,000	2,000,000,000
Common stock, shares issued	901,502,280	800,543,896	737,263,858
Common stock, shares outstanding	901,502,280	800,543,896	737,263,858
Accumulated depreciation		$ 17,773

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Dec. 31, 2021
Income Statement [Abstract]
Revenues
Cost of revenues
Gross profit
Operating expenses
Selling, general and administrative expenses	161,534	280,351	427,132	2,240,437
Total operating expenses	161,534	280,351	427,132	2,240,437
Loss from operations	(161,534)	(280,351)	427,132	2,240,437
Other expense (income)
Change in fair value of derivative liability	(1,136,000)	45,000	2,090,500	(7,348,389)
Change in warrant liability	(851,000)	(178,500)	993,000	(1,782,000)
Loss on disposal of fixed assets			97,555
Loss on write off of prepaid expense				315,000
Financing costs				63,000
Loss on conversion of notes payable	753,406	85,241	62,106
Amortization of original issue discount	216,386	482,234	1,089,902	2,303,973
Gain on settlement of accrued expenses				(12,000)
Interest expense	265,977	215,757	1,000,866	2,008,670
Total other expense (income)	751,231	649,732	5,333,929	(4,451,746)
Income tax expense
Net (Loss) Income	$ 589,697	$ (930,083)	$ (5,761,061)	$ 2,211,309
Net Loss per common share, basic	$ 0	$ 0
Weighted average common shares outstanding, basic	729,067,488	648,640,637	800,543,896	737,263,858
Weighted average common shares outstanding, basic and diluted	1,062,623,257	648,640,637		1,420,563,361
Net Loss per common share, diluted

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (Unaudited) - USD ($)	Common Stock [Member]	Preferred Stock [Member]	Additional Paid-in Capital [Member]	Shares Payable [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Dec. 31, 2020	$ 668,338	$ 1,000	$ 34,086,086		$ (51,560,884)	$ (16,805,460)
Beginning balance, shares at Dec. 31, 2020	668,338,264	1,000,000
Shares Issued for conversion of debt	$ 50,620		1,027,933			1,078,553
Shares Issued for conversion of debt, shares	50,619,573
Shares issued for financing fees	$ 8,000		384,000			392,000
Shares issued for financing fees, shares	8,000,000
Shares issued for services	$ 5,000		279,500	180,000		464,500
Shares issued for services, shares	5,000,000
Reduction in derivative liability			1,602,171			1,602,171
Warrant Exercise	$ 5,306		(9,306)			(4,000)
Warrant exercise, shares	5,306,021
Net (Loss)					2,211,309	2,211,309
Ending balance, value at Dec. 31, 2021	$ 737,264	$ 1,000	37,370,384	180,000	(49,349,575)	(11,060,927)
Ending balance, shares at Dec. 31, 2021	737,263,858	1,000,000
Shares Issued for conversion of debt	$ 58,280		568,326			626,606
Shares Issued for conversion of debt, shares	58,280,038
Shares Issued for  issuance of debt
Shares issued for services	$ 5,000		175,000	(180,000)
Shares issued for services, shares	5,000,000
Reduction in derivative liability			120,000			120,000
Warrant exercise
Net (Loss)					(5,761,061)	(5,761,061)
Ending balance, value at Dec. 31, 2022	$ 800,544	$ 1,000	38,233,710		(55,110,636)	(16,075,382)
Ending balance, shares at Dec. 31, 2022	800,543,896	1,000,000
Shares Issued for conversion of debt	$ 100,958		1,662,030			1,762,988
Shares Issued for conversion of debt, shares	100,958,182
Reduction in derivative liability			511,000			511,000
Net (Loss)					589,697	589,697
Ending balance, value at Mar. 31, 2023	$ 901,502	$ 1,000	$ 40,406,740		$ (54,520,939)	$ (13,211,697)
Ending balance, shares at Mar. 31, 2023	901,502,078	1,000,000

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities:
Net Income (Loss)	$ 589,697	$ (930,083)	$ (5,761,061)	$ 2,211,309
Adjustments to reconcile net loss to net cash (used in) operating activities:
Depreciation				12,695
Amortization of debt discount	216,386	482,234	1,089,901	2,303,945
Change in fair value of derivative liability	(1,136,000)	45,000	2,090,500	(7,348,389)
Change in fair value of warrant liability	(851,000)	(178,500)	993,000	(1,782,000)
Stock-based compensation				464,500
Consulting fees added to note payable principal		137,000	(123,000)	240,000
Interest expense from warrant liability	11,250			881,000
Extension fees added to principal balance	129,644		176,536	250,000
Penalty/other extension fees for notes payable			251,169
Loss (gain) on Conversion of NP			62,105
Loss on Disposal of Fixed assets			97,556
Legal fees for note issuance				17,795
Gain on conversion of notes payable	753,406	85,241
Changes in operating assets and liabilities:
Prepaid expenses		22,500	22,500	(22,500)
Prepaid expense from related party				315,000
Due from related entity		42,473		(10,204)
Accounts payable		1,367	1,588	(124,780)
Accrued expenses	106,694	219,714	576,081	203,356
Due to Related Party
Due to officer		(46,719)		(251,291)
Net cash (used in) operating activities	(179,923)	(119,773)	(523,125)	(2,639,564)
Cash flows from investing activities:
Advances to related party	219,928		(138,917)
Net cash (used in) investing activities	219,928		(138,917)
Cash flows from financing activities:
Advances from related party	(261,963)
Proceeds from Related Party	222,500	100,000	242,985
Repayment of advanced to officer		(75,488)	(46,719)
Proceeds from notes payable			100,000
Payments of notes payable				(125,000)
Proceeds from convertible notes payable			575,000	3,403,750
Payments of convertible notes payable			(306,981)	(540,650)
Net cash provided by (used in) financing activities	(39,463)	24,512	564,285	2,738,100
Net increase (decrease) in cash	542	(95,261)	(97,757)	98,536
Cash at beginning of year	1,043	98,800	98,800	264
Cash at end of year	1,585	3,539	1,043	98,800
Non-Cash Items
Convertible notes and interest paid by officer			(27,176)	253,000
Convertible notes and interest paid by affiliate	1,009,582		(27,176)	53,000
Debt discount from derivative on convertible notes payable	(245,000)	3,750	(641,500)	386,823
Reclass of derivative liability to equity upon repayment/conversions
Reduction in derivative liability from payments on convertible notes payable	(511,000)		(120,000)	(4,000)
Debt discount from issuance of warrants with convertible note payable				1,507,000
Discount on   convertible notes payable			(42,693)	(490,214)
Debit discount for issuance of warrants with convertible note
Conversion of Convertible notes payable	(1,009,582)		(557,760)	(743,583)
Cashless exercise of warrants				5,306
Settlement of derivative liability to APIC				1,743,908
Convertible debt settled through issuance of common shares		421,182	564,501	1,078,552
Shares of common stock issued in relation to debt
Shares issued for accounts payable			(180,000)
Reduction in accrued compensation due to officer				53,000
Additional Paid in Capital from payoff of convertible notes payable
Warrant exercise shares				$ (4,000)

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (Parenthetical)	12 Months Ended
	Dec. 31, 2022 USD ($)
Statement of Cash Flows [Abstract]
Loan Interest	$ 29,449

DESCRIPTION OF BUSINESS

DESCRIPTION OF BUSINESS	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
DESCRIPTION OF BUSINESS	NOTE 1 – DESCRIPTION OF BUSINESS The Company was incorporated in New Jersey as Creative Beauty Supply, Inc. (“Creative”) in August 1995. In March 2004, Creative acquired Global Digital Solutions, Inc., a Delaware corporation (“Global”). The merger was treated as a recapitalization of Global, and Creative changed its name to Global Digital Solutions, Inc. (“the Company”, “we”), Global provided structured cabling design, installation and maintenance for leading information technology companies, federal, state, and local government, major businesses, educational institutions, and telecommunication companies. Going Concern The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”), assuming the Company will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The Company has sustained losses and experienced negative cash flows from operations since inception, and for the three months had net income of approximately $ 590,000 1,136,000 851,000 75,300 216,000 266,000 179,923 54,520,000 13,212,000 The Company needs to raise additional funds immediately and continue to raise funds until they begin to generate sufficient cash from operations and may not be able to obtain the necessary financing on acceptable terms, or at all. The Company will continue to require substantial funds to continue development of its core business. Management’s plans in order to meet the operating cash flow requirements include financing activities such as private placements of common stock, and issuances of debt and convertible debt instruments, and the establishment of strategic relationships which management expects will lead to the generation of additional revenue or acquisition opportunities. While Management believes that the Company will be successful in obtaining the necessary financing to fund operations, there are no assurances that such additional funding will be achieved or that they will succeed in future operations. Our ability to achieve and maintain profitability and positive cash flow is dependent upon our ability to successfully execute the plans to pursue acquisitions and raise the funds necessary to complete such acquisitions. The outcome of these matters cannot be predicted at this time. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern.	NOTE 1 – DESCRIPTION OF BUSINESS We were incorporated in New Jersey as Creative Beauty Supply, Inc. (“Creative”) in August 1995. In March 2004, Creative acquired Global Digital Solutions, Inc., a Delaware corporation (“Global”). The merger was treated as a recapitalization of Global, and Creative changed its name to Global Digital Solutions, Inc. (“the Company”, “we”), Global provided structured cabling design, installation and maintenance for leading information technology companies, federal, state and local government, major businesses, educational institutions, and telecommunication companies. On May 1, 2012, we made the decision to wind down our operations in the telecommunications area and to refocus our efforts in the area of cyber arms technology and complementary security and technology solutions. From August 2012 through November 2013, we were actively involved in managing Airtronic USA, Inc., and effective as of June 16, 2014, we acquired North American Custom Specialty Vehicles (“NACSV”). In July 2014, we announced the formation of GDSI International (f/k/a Global Digital Solutions, LLC) to spearhead our efforts overseas. The Company had limited operations from the NACSV subsidiary from December 31, 2015, until May 13, 2016. During the interim, the Company was pursuing acquisition opportunities and responding to the litigation with the Securities and Exchange Commission. Subsequent to May 13, 2016, the Company has been seeking acquisitions and additional financing. In March of 2019, the Company acquired HarmAlarm (“HA”). HA was formed in 2002 as a private Texas company to pursue Infrared commercial applications in the aviation services area. HA is developing an updated version of the system known as Pilot Assisted Landing Systems (PALS).

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited financial information as of and for the three months ended March 31, 2023, and 2022 has been prepared in accordance with accounting principles generally accepted in the U.S. for interim financial information and with the instructions to Quarterly Report on Form 10-Q and Article 10 of Regulation S-X. In the opinion of management, such financial information includes all adjustments (consisting only of normal recurring adjustments, unless otherwise indicated) considered necessary for a fair presentation of our financial position at such date and the operating results and cash flows for such periods. Operating results for the three months ended March 31, 2023, are not necessarily indicative of the results that may be expected for the entire year or for any other subsequent interim period. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been omitted pursuant to the rules of the U.S. Securities and Exchange Commission, or the SEC. These unaudited financial statements and related notes should be read in conjunction with our Annual Report on Form 10-K that includes the audited financial statements for the year ended December 31, 2022, as filed with the SEC on April 20, 2022. The condensed consolidated balance sheet at December 31, 2022, has been derived from the audited financial statements at that date but does not include all the information and footnotes required by generally accepted accounting principles in the U.S. for complete financial statements. Principles of Consolidation The accompanying consolidated financial statements include the accounts of the Company and our wholly owned subsidiaries, NACSV, GDSI Florida, LLC, Global Digital Solutions, LLC, and Harm Alarm. All intercompany accounts and transactions have been eliminated in consolidation. Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, equity-based transactions, and disclosure of contingent liabilities at the date of the financial statements and revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company believes the following critical accounting policies affect its more significant judgments and estimates used in the preparation of the financial statements. Significant estimates include the derivative liability valuation, deferred tax asset and valuation allowance, and assumptions used in Black-Scholes-Merton, or BSM, or other valuation methods, such as expected volatility, risk-free interest rate, and expected dividend rate. Income Taxes Income taxes are accounted for based upon an asset and liability approach. Accordingly, deferred tax assets and liabilities arise from the difference between the tax basis of an asset or liability and its reported amount in the financial statements. Deferred tax amounts are determined using the tax rates expected to be in effect when the taxes will be paid or refunds received, as provided under currently enacted tax law. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. Income tax expense or benefit is the tax payable or refundable, respectively, for the period plus or minus the change in deferred tax assets and liabilities during the period. Accounting guidance requires the recognition of a financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement with the relevant tax authority. The Company believes its income tax filing positions and deductions will be sustained upon examination and accordingly, no reserves, or related accruals for interest and penalties have been recorded at March 31, 2023, and December 31, 2022. The Company recognizes interest and penalties on unrecognized tax benefits as well as interest received from favorable tax settlements within income tax expense. Cash and Cash Equivalents We consider all highly liquid investments with original maturities of three months or less to be cash equivalents. We maintain our cash in high-quality financial institutions. The balances, at times, may exceed federally insured limits. As of March 31, 2023, the bank balance is not over the federally insured limit. As of March 31, 2023 and December 31, 2022, we had no Fair Value of Financial Instruments The carrying value of cash, accounts payable and accrued expenses approximate their fair values based on the short-term maturity of these instruments. The carrying amounts of debt were also estimated to approximate fair value. The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement). This fair value measurement framework applies at both initial and subsequent measurement. The three levels of the fair value hierarchy defined by ASC 820 are as follows: ● Level 1 – Quoted prices in active markets for identical assets or liabilities ● Level 2 – Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable, either directly or indirectly ● Level 3 – Significant unobservable inputs that cannot be corroborated by market data. Derivative Financial Instruments We account for conversion options embedded in convertible notes payable in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standard Codification (“ASC’) 815, “Derivatives and Hedging” Embedded Derivatives Derivative Liabilities Derivatives and Hedging – Contracts in Entity’s own Equity Change in fair value of derivative liability Earnings (Loss) Per Share (“EPS”) Basic EPS is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding. Diluted EPS includes the effect from potential issuance of common stock, such as stock issuable pursuant to the exercise of stock options and warrants and the assumed conversion of convertible notes. The following table summarizes the securities that were excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive: Securities excluded from the diluted per share calculation Three Months Ended March 31, 2023 2022 Convertible notes and accrued interest 453,945,414 406,572,394 Preferred Stock 296,201,242 255,284,000 Stock options 13,650,002 13,650,002 Warrants 78,346,875 56,096,875 Potentially dilutive securities 847,937,711 731,603,271 Stock Based Compensation In accordance with ASC 718, “Compensation – Stock Compensation” the Company measures the cost of employee services received in exchange for share-based compensation measured at the grant date fair value of the award. The Company’s accounting policy for equity instruments issued to advisors, consultants, and vendors in exchange for goods and services follows the provisions of FASB ASC 505-50 . Convertible Instruments The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with accounting standards for “Accounting for Derivative Instruments and Hedging Activities.” Accounting standards generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur, and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. accounting standards also provide an exception to this rule when the host instrument is deemed to be conventional as defined under professional standards as “The Meaning of Conventional Convertible Debt Instrument.” The Company accounts for convertible instruments (when it has determined that the embedded conversion options should not be bifurcated from their host instruments) in accordance with professional standards when “Accounting for Convertible Securities with Beneficial Conversion Features,” as those professional standards pertain to “Certain Convertible Instruments.” Accordingly, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Original issue discounts (“OID”) under these arrangements are amortized over the term of the related debt to their earliest date of redemption. The Company also records when necessary deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. ASC 815-40 provides that, among other things, generally, if an event is not within the entity’s control could or require net cash settlement, then the contract shall be classified as an asset or a liability. Convertible Securities Based upon ASC 815-15, we have adopted a sequencing approach regarding the application of ASC 815-40 to convertible securities. We will evaluate our contracts based upon the earliest issuance date. In the event partial reclassification of contracts subject to ASC 815-40-25 is necessary, due to our inability to demonstrate we have sufficient shares authorized and unissued, shares will be allocated on the basis of issuance date, with the earliest issuance date receiving first allocation of shares. If a reclassification of an instrument were required, it would result in the instrument issued latest being reclassified first. Recent Accounting Pronouncements Management is evaluating the new accounting pronouncements but does not expect them to have material impact on our financial position or results of operations. Management’s Evaluation of Subsequent Events The Company evaluates events that have occurred after the balance sheet date of March 31, 2023, through the date which the financial statements were issued. Based upon the review, other than described in Note 12 – Subsequent Events, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the financial statements.	NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Going Concern The accompanying financial statements have been prepared assuming we will continue as a going concern, which contemplates the realization of assets and the liquidation of liabilities in the normal course of business. We have sustained losses and experienced negative cash flows from operations since inception, for the current year ended December 31, 2022, which we had a net loss of $ 5,761,061 used net cash of $ 523,125 to fund operating activities. On December 31, 2022, we had cash of $ 1,043 an accumulated deficit of $ 55,110,636 a working capital deficit of $ 16,076,425 16,075,382 . We have funded our activities to date almost exclusively from equity and debt financings. Our cash position is critically deficient, and payments essential to our ability to operate are not being made in the ordinary course. Failure to raise capital in the coming days to fund our operations and failure to generate positive cash flow to fund such operations in the future will have a material adverse effect on our financial condition. These factors raise substantial doubt about our ability to continue as a going concern. We need to raise additional funds immediately and continue to raise funds until we begin to generate sufficient cash from operations, and we may not be able to obtain the necessary financing on acceptable terms, or at all. We will continue to require substantial funds to continue development of our core business. Management’s plans in order to meet our operating cash flow requirements include financing activities such as private placements of common stock, and issuances of debt and convertible debt instruments, and the establishment of strategic relationships which we expect will lead to the generation of additional revenue or acquisition opportunities. While we believe that we will be successful in obtaining the necessary financing to fund our operations, there are no assurances that such additional funding will be achieved or that we will succeed in our future operations. Our ability to achieve and maintain profitability and positive cash flow is dependent upon our ability to successfully execute the plans to pursue acquisitions and raise the funds necessary to complete such acquisitions. The outcome of these matters cannot be predicted at this time. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern. Principles of Consolidation The accompanying consolidated financial statements include the accounts of the Company and our wholly owned subsidiaries, NACSV, GDSI Florida, LLC, Global Digital Solutions, LLC and HarmAlarm. All intercompany accounts and transactions have been eliminated in consolidation. Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, equity-based transactions and disclosure of contingent liabilities at the date of the financial statements and revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company believes the following critical accounting policies affect its more significant judgments and estimates used in the preparation of the financial statements. Significant estimates include the derivative liability valuation, deferred tax asset and valuation allowance, and assumptions used in Black-Scholes-Merton, or BSM, or other valuation methods, such as expected volatility, risk-free interest rate, and expected dividend rate. Income Taxes Income taxes are accounted for based upon an asset and liability approach. Accordingly, deferred tax assets and liabilities arise from the difference between the tax basis of an asset or liability and its reported amount in the financial statements. Deferred tax amounts are determined using the tax rates expected to be in effect when the taxes will actually be paid or refunds received, as provided under currently enacted tax law. Valuation allowances are, when necessary, to reduce deferred tax assets to the amount expected to be realized. Income tax expense or benefit is the tax payable or refundable, respectively, for the period plus or minus the change in deferred tax assets and liabilities during the period. Accounting guidance requires the recognition of a financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement with the relevant tax authority. The Company believes its income tax filing positions and deductions will be sustained upon examination and accordingly, no reserves, or related accruals for interest and penalties have been recorded at December 31, 2022, and 2021 The Company recognizes interest and penalties on unrecognized tax benefits as well as interest received from favorable tax settlements within income tax expense. On December 22, 2017, the President of the United States signed and enacted into law H.R. 1 (the “Tax Reform Law”). The Tax Reform Law, effective for tax years beginning on or after January 1, 2018, except for certain provisions, resulted in significant changes to existing United States tax law, including various provisions that are expected to impact the Company. The Tax Reform Law reduces the federal corporate tax rate from 34% to 21% effective January 1, 2018. The Company analyzed the provisions of the Tax Reform Law to assess the impact on the Company’s consolidated financial statements and determined it had no material impact. Cash and Cash Equivalents We consider all highly liquid investments with original maturities of three months or less to be cash equivalents. Prepaid expenses In 2021 management reassessed the viability of testing the PALS system in house. Management reviewed at alternative choices and decided that in house testing was no longer feasible and will outsource the Pals system testing. As a result of this management decision the prepaid expense was written off and the Company incurred a loss on the write off of $315,000, and $205,000 was charged to Mr. Delgado accrued compensation and Due to officer accounts. Fair Value of Financial Instruments The carrying value of cash, accounts payable and accrued expenses approximate their fair values based on the short-term maturity of these instruments. The carrying amounts of debt were also estimated to approximate fair value. The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement). This fair value measurement framework applies at both initial and subsequent measurement. The three levels of the fair value hierarchy defined by ASC 820 are as follows: ● Level 1 – Quoted prices in active markets for identical assets or liabilities ● Level 2 – Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable, either directly or indirectly ● Level 3 – Significant unobservable inputs that cannot be corroborated by market data. Derivative Financial Instruments We account for conversion options embedded in convertible notes payable in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standard Codification (“ASC’) 815, “Derivatives and Hedging” Embedded Derivatives Derivative Liabilities Derivatives and Hedging – Contracts in Entity’s own Equity Change in fair value of derivative liability Earnings (Loss) Per Share (“EPS”) Basic EPS is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding. Diluted EPS includes the effect from potential issuance of common stock, such as stock issuable pursuant to the exercise of stock options and warrants and the assumed conversion of convertible notes. The following table summarizes the securities that were excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive: Securities excluded from the diluted per share calculation Year Ended December 31, December 31, 2022 2021 Convertible notes and accrued interest 268,563,014 361,265,001 Preferred Stock 296,201,242 227,787,627 Stock options 12,900,000 12,900,000 Warrants 66,446,875 81,346,875 Potentially dilutive securities 644,111,131 683,299,503 Stock Based Compensation In accordance with ASC 718, “Compensation – Stock Compensation” the Company measures the cost of employee services received in exchange for share-based compensation measured at the grant date fair value of the award. The Company’s accounting policy for equity instruments issued to advisors, consultants, and vendors in exchange for goods and services follows the provisions of FASB ASC 505-50 . Schedule of warranty liability Warrant liability 2022 2021 Warrant Liability balance at beginning of period 606,000 560,000 Additions to warrant liability — (1,736,000 ) Change in fair value 993,000 1,782,000 Balance at end of period 1,599,000 606,000 At December 31,2022 the fair Value of the warrant liability was estimated using a Black Scholes model with the following weighted-average inputs: the price of the Company’s Common stock of $ 0.0249 3.0% 173.54% 185.9% 205.9% Convertible Instruments The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with accounting standards for “Accounting for Derivative Instruments and Hedging Activities.” Accounting standards generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur, and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. Professional standards also provide an exception to this rule when the host instrument is deemed to be conventional as defined under professional standards as “The Meaning of Conventional Convertible Debt Instrument.” The Company accounts for convertible instruments (when it has determined that the embedded conversion options should not be bifurcated from their host instruments) in accordance with professional standards when “Accounting for Convertible Securities with Beneficial Conversion Features,” as those professional standards pertain to “Certain Convertible Instruments.” Accordingly, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Original issue discounts (“OID”) under these arrangements are amortized over the term of the related debt to their earliest date of redemption. The Company also records when necessary deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. ASC 815-40 provides that, among other things, generally, if an event is not within the entity’s control could or require net cash settlement, then the contract shall be classified as an asset or a liability. Convertible Securities Based upon ASC 815-15, we have adopted a sequencing approach regarding the application of ASC 815-40 to convertible securities. We will evaluate our contracts based upon the earliest issuance date. In the event partial reclassification of contracts subject to ASC 815-40-25 is necessary, due to our inability to demonstrate we have sufficient shares authorized and unissued, shares will be allocated on the basis of issuance date, with the earliest issuance date receiving first allocation of shares. If a reclassification of an instrument were required, it would result in the instrument issued latest being reclassified first.

ACCRUED EXPENSES

ACCRUED EXPENSES	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Payables and Accruals [Abstract]
ACCRUED EXPENSES	NOTE 3 – ACCRUED EXPENSES As of March 31, 2023, and December 31, 2022, accrued expenses consist of the following amounts: Schedule of accrued expenses March 31, December 31, Accrued compensation to executive officers $ 128,334 141,997 Accrued professional fees and settlements 55,163 73,890 Accrued interest 1,809,541 1,812,914 Total accrued expenses $ 1,993,038 $ 2,028,801	NOTE 3 – ACCRUED EXPENSES Accrued expenses consist of the following amounts: Schedule of Accrued Expenses December 31, December 31, 2022 2021 Accrued compensation to executive officers $ 141,997 $ 90,834 Accrued professional fees and settlements 73,890 86,392 Accrued interest 1,812,914 1,304,684 Total accrued expenses $ 2,028,801 $ 1,481,910

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	NOTE 4 – FAIR VALUE MEASUREMENTS We had no Level 1 or Level 2 assets and liabilities at March 31, 2023, and December 31, 2022. The Derivative liabilities are Level 3 fair value measurements. The following is a summary of activity of Level 3 liabilities during the periods ended March 31, 2023, and December 31, 2022: Schedule of fair value derivative liabilities March 31, December 31, Derivative liability: Balance at beginning of period $ 3,421,000 $ 809,000 Additions 245,000 641,500 Settlements (511,000 ) (120,000 ) Change in fair value (1,136,000 ) 2,090,500 Balance at end of year $ 2,019,000 $ 3,421,000 Schedule of fair value derivative liabilities March 31, December 31, Warrant liability: Balance at beginning of period $ 1,599,000 $ 606,000 Additions - - Change in fair value (851,000 ) ( 993,000 ) Balance at end of year $ 748,000 $ 1,599,000 Embedded Derivative Liabilities of Convertible Notes At March 31, 2023, the fair value of the bifurcated embedded derivative liabilities of convertible notes was estimated using the following weighted-average inputs: the price of the Company’s common stock of $ 0.05 4.5% 5.0% 173.74% 185.90% 0% 0%	NOTE 4 – FAIR VALUE MEASUREMENTS We had no Level 1 or Level 2 assets and liabilities at December 31, 2022, and December 31, 2021. The Derivative liabilities are Level 3 fair value measurements. The following is a summary of activity of Level 3 liabilities during the years ended December 31, 2022, and 2021: Schedule of Fair Value of Liabilities Balance at beginning of period $ 809,000 $ 9,367,159 Additions 641,500 266,000 Settlements (120,000 ) (1,580,000 ) Change in fair value 2,090,500 (7,244,159 ) Balance at end of year $ 3,421,000 $ 809,000 Embedded Derivative Liabilities of Convertible Notes At December 31, 2022, the fair value of the bifurcated embedded derivative liabilities of convertible notes was estimated using the following weighted-average inputs: risk free interest rate — 4.73 1 173.74 0% 0.08 0.31 173.74

NOTE PAYABLE

NOTE PAYABLE	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Debt Disclosure [Abstract]
NOTE PAYABLE	NOTE 5 – NOTE PAYABLE During August 2017, Dragon Acquisitions, a related entity owned by William Delgado, and an individual lender entered into a promissory note agreement for $ 20,000 2,000 22,000 December 31, 2022 20,000 On December 22, 2017, the Company entered into a financing agreement with Parabellum, an accredited investor, for $1.2 million, which was then amended in 2020 and increased to $ 2,550,000 2,550,000 On December 23, 2017 (the “Effective Date”) the Company entered into a $ 485,000 7% The Company shall make mandatory prepayment in the following amounts and at the following times – ● $1,000 on the Effective Date. ● $50,000 on the date on which the judge presiding over the lawsuit issues a ruling or decision in which the lawsuit survives a motion to dismiss. ● $50,000 on the date on which discovery closes with respect to the lawsuit. ● $100,000 on the date on which the judge presiding over the lawsuit issues a ruling or decision in which the lawsuit survives a motion for summary judgement on the claims. Under the terms of the Vox note consulting agreement (see Note 6), any unpaid consulting fees subsequent to December 2017 causes a default on the note with unpaid consulting fees to be added to the principal of the note. As of March 31, 2023, and December 31, 2022. and through the date of this report, the principal balance totaling $ 861,500 290,813 On December 26, 2017 (the “Effective Date”), the Company entered into a $ 485,000 7% ● $1,000 on the Effective Date. ● $50,000 on the date on which the judge presiding over the lawsuit issues a ruling or decision in which the lawsuit survives a motion to dismiss. ● $50,000 on the date on which discovery closes with respect to the lawsuit. ● $100,000 on the date on which the judge presiding over the lawsuit issues a ruling or decision in which the lawsuit survives a motion for summary judgement on the claims. Under the terms of the RLT note consulting agreement (see Note 6), any unpaid consulting fees subsequent to December 2017 causes a default on the note with unpaid consulting fees to be added to the principal of the note. as of March 31, 2023, and December 31, 2022, and through the date of this report the principal balance totaling $ 861,500 290,513 . Through the date of this report, monthly consulting fees have not been repaid and were added to the principal balance of the note. The note remains in default. However, RLT has voluntarily refrained from making demand prior to the resolution funding date. RLT was granted a first priority security interest in the litigation proceeds and is pari passu to Parabellum and Vox. To that end, they share in the litigation in a priority position to proceed to repay the note. During April 2018, the Company entered into a two-month $ 36,000 5,000 11,000 During May 2018, the Company entered into an Investment Return Purchase Agreement with an accredited investor (the “Purchaser”) for proceeds of $200,000 (the “Investment Agreement”). Under the terms of the Investment Agreement, the Company agreed to pay the Purchaser the $200,000 proceeds plus a 10% return, or $20,000 (the “Investment Return”) within three (3) months from the date of the Investment Agreement. Such Investment Return shall be paid earlier if the Company secures funding totaling $500,000 within 90 days from the date of the Investment Agreement. The lender has extended the maturity date to December 31, 2021. In addition, the Company agreed to issue to the Purchaser 2,000,000 warrants to purchase common stock of the Company at an exercise price of $0.01 per share, exercisable for a period of three (3) years. As of March 31, 2023, and December 31, 2022, and through the date of this report, the $200,000 principal and $20,000 Investment Return remained outstanding. The note is past the maturity date and has not been repaid through the date the financial statements were issued. On May 12, 2020, the Company obtained a Paycheck Protection Program (“PPP”) loan in the amount of $ 103,125 1% The Company has requested debt forgiveness from the SBA. As of March 31, 2023, and December 31, 2022, and through the date of this report the SBA has not responded to the request and NNVA has waived the monthly payment. Convertible Notes Payable During January 2015, the Company entered into a one-year $ 78,750 8% 17,044 During January 2015, the Company entered into a two-year convertible note payable for up to $ 250,000 10% 10,564 On April 7, 2020, the Company entered into a convertible promissory note arrangement with Auctus Fund, LLC in the principal amount of $ 197,000 12% February 7, 2021 197,000 70,920 On February 25, 2021, the Company and Leonite Capital LLC entered into a securities purchase agreement for a prime rate plus 8% 2,285,714 On March 1, 2021, the Company received the first tranche of $1,000,000 from Leonite Capital. In connection with the note, the Company issued 20,000,000 warrants, exercisable at $0.10, with a 10-year term and contain full-ratchet anti-dilution protection provisions, with a fair value of $507,000. The Company also issued 4,000,000 shares of common stock as commitment shares to the noteholder, with a fair value of $204,000. The warrants and the commitment shares resulted in a debt discount of $1,000,000, which will be amortized using the effective interest method over the life of the convertible note, and the excess of $101,000 recognized as interest expense at issuance. The warrants were evaluated to be classified as a liability, as based on the various convertible notes outstanding with variable conversion rates it cannot be determined if there are sufficient authorized shares available during the contract period. On June 14, 2022, Leonite Capital converted $ 204,080 .01 20,408,015 On February 8, 2023 Leonite Capital converted $87,754 of principal, and $14,246 of interest and fees at a conversion price of $.01 for 10,000,000 shs of common stock. On February 21, 2023 Leonite Capital converted $105,076 of principal, and $44,924 of interest and fees at a conversion price of $.01 for 15,000,000 shs of common stock. On March 1, 2023 Leonite Capital converted $193,184 of principal, and interest $6,816 of $ principal and fees at a conversion price of $.01 for 20,000,000 shs of common stock. On March 17, 2023 Leonite Capital converted $190,637 of principal, and interest and fees of $9,363 at a conversion price of $.01 for 20,000,000 shs of common stock. On January 4, 2023, the Company and Leonite Capital, LLC. entered into a security purchase agreement for a 8% 41,667 On March 25, 2021, the Company and GS Capital Partners LLC entered into a securities purchase agreement for a prime rate plus 8% 2,285,714 On April 1, 2021, the Company received the first tranche of $1,142,857 from GS Capital, LLC. In connection with the note, the Company issued 20,000,000 warrants, exercisable at $0.10, with a 10-year term and contain full-ratchet anti-dilution protection provisions, with a fair value of $507,000. The Company also issued 4,000,000 shares of common stock as commitment shares to the noteholder, with a fair value of $204,000. The warrants and the commitment shares resulted in a debt discount of $1,000,000, which will be amortized using the effective interest method over the life of the convertible note, and the excess of $101,000 recognized as interest expense at issuance. The warrants were evaluated to be classified as a liability, as based on the various convertible notes outstanding with variable conversion rates it cannot be determined if there are sufficient authorized shares available during the contract period. The Company received the second tranche as follows; May 24, 2021, $796,000, July 15, 2021, $90,000, and July 21, 2021, $208,500. On April 21, 2022, GS Capital, LLC converted $ 31,229 .01 3,122,914 On February 7, 2023 GS Capital Partners, LLC. converted $ 53,475 13,886 .01 6,736,045 On February 23, 2023 GS Capital Partners, LLC. converted $ 65,000 17,278 .01 8,277,753 On March 7, 2023 GS Capital Partners, LLC. converted $ 80,000 21,633 .01 10,163,288 On March 17, 2023 GS Capital Partners, LLC. converted $ 85,000 23,311 .01 10,831,096 On August 18, 2022, the Company and GS Capital Partners LLC entered into a securities purchase agreement for a 10% convertible note in the aggregate principal of $172,000. A lump- sum interest payment for twelve (12) months shall be immediately due on the Issue date and shall be added to the principal balance and payable on the maturity date August 18, 2023. Principal payments shall be made in nine (9) installments each in the amount of $21,022.22 commencing on the one hundred twentieth(120 th On June 7, 2021, the Company and Geneva Roth Remark Holdings, Inc., entered into a security purchase agreement (“SPA”) for an 8% 251,625 June 7, 2022 22,875 20,130 On December 10, 2021, the Company and Sixth Street Lending LLC, entered into a security purchase agreement for a 8% 128,750 December 10, 2022 On February 3, 2022, the Company and Sixth Street Lending LLC, entered into a security purchase agreement for a 8% 103,750 February 3, 2023 On March 25, 2022, the Company and Sixth Street Lending LLC, entered into a security purchase agreement for a 12% 258,638 March 25, 2023 On June 14, 2022, the Company and 1800 Diagonal Lending LLC, f/k/a Sixth Street Lending LLC entered into a security purchase agreement for a 8% 128,750 June 14, 2023 On November 7, 2022, the Company and Gary Shover entered into a security purchase agreement for a 12% 75,000 May 7, 2023 75,000 3,750 On December 14, 2022 , the Company and Ronal Minor entered into a security purchase agreement for a 12% Convertible Note in the aggregate principal of $25,000 due on June 14, 2023. The note is convertible into shares of common stock of the Company at a fixed conversion price of $0.139 per share. The investor shall also receive warrants to purchase 500,000 common shares at $0.139 per share As of March 31, 2023, and December 31, 2022, and through the date of this report, the principal balance totaling $25,000 and interest of $750 is outstanding. On February 6, 2023 the Company and Fourth Man, LLC entered into a Securities purchase agreement for 12% 165,000 16,500	NOTE 5 – NOTE PAYABLE Convertible Note Payable During January 2015, the Company entered into a one-year $ 78,750 8 35,015,467 33,408,936 48,610 During January 2015, the Company entered into a two-year convertible note payable for up to $ 250,000 10 59,514 On April 7, 2020, the Company entered into a convertible promissory note arrangement with Actus Fund, LLC in the principal amount of $197,000. The principal amount of the note with interest at 12% is due on February 7, 2021. The note is convertible into shares of the Company’s common stock. The conversion price shall equal the lessor of (i) Current Market price or (ii) Variable Market price as defined as Market Price less a 50% discount price. As of December 31, 2022, and through the date of this report, the principal balance totaling $197,000 is outstanding. On August 5, 2020, The Company and Adar Alef, LLC entered into a security purchase agreement in the aggregate principal of $ 150,000 5 On February 25, 2021, the Company and Leonite Capital LLC entered into a securities purchase agreement for a prime rate plus 8 2,285,714 On March 1, 2021, the Company received the first tranche of $1,000,000 from Leonite Capital. In connection with the note, the Company issued 20,000,000 warrants, exercisable at $0.10, with a 10-year term and contain full-ratchet anti-dilution protection provisions, with a fair value of $507,000. The Company also issued 4,000,000 shares of common stock as commitment shares to the noteholder, with a fair value of $204,000. The warrants and the commitment shares resulted in a debt discount of $1,000,000, which will be amortized using the effective interest method over the life of the convertible note, and the excess of $101,000 recognized as interest expense at issuance. The warrants were evaluated to be classified as a liability, as based on the various convertible notes outstanding with variable conversion rates it cannot be determined if there are sufficient authorized shares available during the contract period. As of December 31, 2022, and through the date of this report, the principal balance totaling $ 970,111 On March 25, 2021, the Company and GS Capital Partners LLC entered into a securities purchase agreement for a prime rate plus 8 2,285,714 On April 1, 2021, the Company received the first tranche of $1,142,857 from GS Capital, LLC. In connection with the note, the Company issued 20,000,000 warrants, exercisable at $0.10, with a 10-year term and contain full-ratchet anti-dilution protection provisions, with a fair value of $507,000. The Company also issued 4,000,000 shares of common stock as commitment shares to the noteholder, with a fair value of $204,000. The warrants and the commitment shares resulted in a debt discount of $1,000,000, which will be amortized using the effective interest method over the life of the convertible note, and the excess of $101,000 recognized as interest expense at issuance. The warrants were evaluated to be classified as a liability, as based on the various convertible notes outstanding with variable conversion rates it cannot be determined if there are sufficient authorized shares available during the contract period. The Company received the second tranche as follows; May 24, 2021, $796,000, July 15, 2021, $90,000, and July 21, 2021, $208,500. As of December 31, 2022, and through the date of this report, the principal balance totaling $2,141,632 is outstanding. On June 7, 2021, the Company and Geneva Roth Remark Holdings, Inc., entered into a security purchase agreement (“SPA”) for an 8 251,625 June 7, 2022 22,875 228,750 20,130 On February 3, 2022, the Company and Sixth Street Lending LLC entered into a security purchase agreement for a 8 % Convertible Note in the aggregate principal of $ 103,750 . is due on February 3, 2023 . The note is convertible into shares of common stock of the Company. The conversion price is equal to the Variable Conversion price which is defined as 65% of the Market Price for the average of the lowest two trading dates during a fifteen-day trading period ending on the latest complete trading date prior to the Conversion date. As of December 31, 2022, and through the date of this report, the principal balance totaling $131,096 is outstanding. On March 25, 2022, the Company and Sixth Street Lending LLC entered into a security purchase agreement for a 8% Convertible Note in the aggregate principal of $ 258,638 March 25, 2023 On June 14, 2022, the Company and Diagonal Leasing entered into a security purchase agreement for a 8 128,750 June 14, 2023 On August 18, 2022, the Company and GS Capital Partners, LLC. entered into a security purchase agreement for a 10% 172,000 August 18, 2023 On November 7, 2022, the Company and Gary Shover, entered into a security purchase agreement for a 12% 75,000 May 7, 2023 On December 14, 2022, the Company and Ronal Minor entered into a security purchase agreement for a 12% 25,000 June 14, 2023 On August 17, 2020, the Company and Harbor Gates entered into a security purchase agreement for a 10 165,000 May 17, 2021 On May 20, 2020, the Company and GS Capital Partners, LLC entered into a 10 165,000 February 20, 2021 On April 6, 2020, the Company and Power Up Lending Group entered into a security purchase agreement for a 10 53,000 April 6, 2021 On May 10, 2019, the Company and GHS Investments LLC entered into a security agreement for a 10 335,000 February 10, 2020 On June 11, 2021, interest on the note in the amount of $115,200.00 was converted into 8,000,000 shares of the Company’s common stock. The outstanding balance of $761,005, as of October 21, 2021, was converted into 25,500,000 shares of the Company’s common stock. The lender also received the 23,000,000 warrants. The Company recognized a gain of $844,797.00 on the conversions of June 11, 2021, and October 21, 2021. The fair value of the 25,500,000 shares issued was approximately $729,300.00 Notes Payable During August 2017, Dragon Acquisitions, a related entity owned by William Delgado, and an individual lender entered into a Promissory Note agreement for $ 20,000 2,000 22,000 20,000 On December 22, 2017, the Company entered into a financing agreement with Parabellum, an accredited investor, for $1.2 million, amended in 2019 and increased to $1,850,000. Under the terms of the agreement, the Company is to receive milestone payments based on the progress of the Company’s lawsuit (Note 6) for damages against Grupo Rontan Metalurgica, S.A (the “Lawsuit”). Such milestone payments consist of (i) an initial purchase price payment of $300,000, which the Company received on December 22, 2017, (ii) $150,000 within 30 days of the Lawsuit surviving a motion to dismiss on the primary claims, (iii) $100,000 within 30 days of the close of all discovery in the Lawsuit and (iv) $650,000 within 30 days of the Lawsuit surviving a motion for summary judgment and challenges on the primary claims. As part of the agreement, the Company shall pay the investor an investment return of 100% of the litigation proceeds to recoup all money invested, plus 27.5% of the total litigation proceeds received by the Company. $300,000 was received by the Company in December 2017. As of December 31, 2022, and through the date of this report, the $ 2,550,000 On December 23, 2017 (the “effective date”), the Company entered into a $ 485,000 7 ● $1,000 on the effective date. ● $50,000 on the date on which the judge presiding over the lawsuit issues a ruling or decision in which the lawsuit survives a motion to dismiss. ● $50,000 on the date on which discovery closes with respect to the lawsuit. ● $100,000 on the date on which the judge presiding over the lawsuit issues a ruling or decision in which the lawsuit survives a motion for summary judgement on the claims. Under the terms of the Vox note consulting agreement (Note 6), any unpaid consulting fees subsequent to December 2017 causes a default on the note with unpaid consulting fees to be added to the principal of the note. During the years ended December 31, 2022, and 2021, consulting fees totaling $ 120,000 861,500 926,500 On December 26, 2017 (the “effective date”), the Company entered into a $ 485,000 7 ● $1,000 on the effective date. ● $50,000 on the date on which the judge presiding over the lawsuit issues a ruling or decision in which the lawsuit survives a motion to dismiss. ● $50,000 on the date on which discovery closes with respect to the lawsuit. ● $100,000 on the date on which the judge presiding over the lawsuit issues a ruling or decision in which the lawsuit survives a motion for summary judgement on the claims. Under the terms of the RLT note consulting agreement (Note 6), any unpaid consulting fees subsequent to December 2017 causes a default on the note with unpaid consulting fees to be added to the principal of the note. During the year ended December 31, 2022, and 2021, consulting fees totaling $ 120,000 861,500 919,500 During April 2018, the Company entered into a two-month $ 36,000 31,000 5,000 11,000 During May 2018, the Company entered into an Investment Return Purchase Agreement with an accredited investor (the “Purchaser”) for proceeds of $200,000 (the “Investment Agreement”). Under the terms of the Investment Agreement, the Company agreed to pay the Purchaser the $200,000 proceeds plus a 10% return, or $20,000 (the “Investment Return”) within three (3) months from the date of the Investment Agreement. Such Investment Return shall be paid earlier if the Company secures funding totaling $500,000 within 90 days from the date of the Investment Agreement. In addition, the Company agreed to issue to the Purchaser 2,000,000 warrants to purchase common stock of the Company at an exercise price of $0.01 per share, exercisable for a period of three years and expired May 2021. The warrants were valued using the Black Scholes Merton model, resulting in a fair value of $13,000 which were recorded as a discount on the note. The key valuation assumptions used consist, in part, of the price of the Company’s common stock of $0.007 at issuance date; a risk-free interest rate of 2.75% and estimated volatility of the Company’s common stock of 220%. As of December 31, 2022, and through the date of this report, the $200,000 principal and $20,000 Investment Return remained outstanding and is in default. During June 2018, the Company entered in to a one-year $ 300,000 150,000 150,000 The June 2018 note bears a personal guarantee by William Delgado, the Chief Executive Officer of the Company. As further security for the note, Mr. Delgado has also pledged the 1,000,000 Convertible Preferred Shares of the Company that he owns, as well as 5,000,000 common shares of SHMP, another public company in which Mr. Delgado is a director and Chief Financial Officer. On May 12, 2020, the Company and BBVA USA entered into a 1 103,125

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 6 – COMMITMENTS AND CONTINGENCIES Consulting agreements The Company entered into two consulting agreements (see Note 5) in May 2016, for services to be provided in connection towards the resolution of the Rontan lawsuit (below). The consulting agreements includes a monthly retainer payment of $10,000 to each consultant. The agreement also includes consideration of 5,000,000 shares of restricted common stock of the Company, plus a 5% cash consideration of the Resolution Progress Funding, (defined as upon the retention of legal counsel and receipt of funding for the litigation), as of the Resolution Progress Funding date and 10,000,000 shares of restricted common stock of the Company and a 5% cash consideration of the Resolution Funding amount (defined as a settlement or judgement in favor of the Company by Rotan), at the Resolution Funding date. The Resolution Progress funding was met on December 22, 2017. Share Purchase and Sale Agreement for Acquisition of Grupo Rontan Electro Metalurgica, S.A. Effective October 13, 2015, the Company (as “Purchaser”) entered into the SPSA dated October 8, 2015 with Joao Alberto Bolzan and Jose Carlos Bolzan, both Brazilian residents (collectively, the “Sellers”) and Grupo Rontan Electro Metalurgica, S.A., a limited liability company duly organized and existing under the laws of Federative Republic of Brazil (“Rontan”) (collectively, the “Parties”), pursuant to which the Sellers agreed to sell 100% of the issued and outstanding shares of Rontan to the Purchaser on the closing date. The purchase price shall consist of a cash amount, a stock amount and an earn-out amount as follows: (i) Brazilian Real (“R”) $100 million (approximately US$26 million) to be paid by the Purchaser in equal monthly installments over a period of forty eight (48) months following the closing date; (ii) an aggregate of R$100 million (approximately US$26 million) in shares of the Purchaser’s common stock, valued at US$1.00 per share; and (iii) an earn-out payable within ten business days following receipt by the Purchaser of Rontan’s audited financial statements for the 12-months ended December 31, 2017, 2018 and 2019. The earn-out shall be equal to the product of (i) Rontan’s earnings before interest, taxes, depreciation and amortization (“EBITDA”) for the last 12 months, and (ii) twenty percent and is contingent upon Rontan’s EBITDA results for any earn-out period being at least 125% of Rontan’s EBITDA for the 12-months ended December 31, 2015. It is the intention of the parties that the stock amount will be used by Rontan to repay institutional debt outstanding as of the closing date. Under the terms of a Finders Fees Agreement dated April 14, 2014, we have agreed to pay RLT Consulting Inc., a related party, a fee of 2% (two percent) of the Transaction Value, as defined in the agreement, of Rontan upon closing. The fee is payable one-half in cash and one-half in shares of our common stock. Specific conditions to closing consist of: a) Purchaser’s receipt of written limited assurance of an unqualified opinion with respect to Rontan’s audited financial statements for the years ended December 31 2013 and 2014 (the “Opinion”); b) The commitment of sufficient investment by General American Capital Partners LLC (the “Institutional Investor”), in the Purchaser following receipt of the Opinion; c) The accuracy of each Parties’ representations and warranties contained in the SPSA; d) The continued operation of Rontan’s business in the ordinary course; e) The maintenance of all of Rontan’s bank credit lines in the maximum amount of R$200 million (approximately US$52 million) under the same terms and conditions originally agreed with any such financial institutions, and the maintenance of all other types of funding arrangements. As of the date of the SPSA, Rontan’s financial institution debt consists of not more than R$200 million (approximately US$52 million), trade debt of not more than R$50 million (approximately US$13 million) and other fiscal contingencies of not more that R$95 million (approximately US$24.7 million); f) Rontan shall enter into employment or consulting service agreements with key employees and advisors identified by the Purchaser, including Rontan’s Chief Executive Officer; and g) The Sellers continued guarantee of Rontan’s bank debt for a period of 90 days following issuance of the Opinion, among other items. The Institutional Investor has committed to invest sufficient capital to facilitate the transaction, subject to receipt of the Opinion, as well as the ability to acquire 100% of the outstanding stock of Rontan at a price of $200 million BR, and the Company can acquire 100% of all real estate held by Rontan. Subject to satisfaction or waiver of the conditions precedent provided for in the SPSA, the closing date of the transaction shall take place within 10 business days from the date of issuance of the Opinion. Rontan is engaged in the manufacture and distribution of specialty vehicles and acoustic/visual signaling equipment for the industrial and automotive markets. Subsequent to December 31, 2015, on April 1, 2016, we believed that we had satisfied or otherwise waived the conditions to closing (as disclosed under the SPSA, the closing was subject to specific conditions to closing, which were waivable by us,) and advised the Sellers of our intention to close the SPSA and demanded delivery of the Rontan Securities. The Sellers, however, notified us that they intend to terminate the SPSA. We believe that the Sellers had no right to terminate the SPSA and that notice of termination by the Sellers was not permitted under the terms of the SPSA. On January 31, 2018, we announced that we initiated a lawsuit for damages against Grupo Rontan Metalurgica, S. A, (“Rontan”) and that company’s controlling shareholders, Joao Alberto Bolzan and Jose Carlos Bolzan. The action has been filed in the United States District Court for the Southern District of Florida. The complaint alleges that Rontan is wholly-owned by Joao Bolzan and Jose Bolzan. In the complaint, we further allege that Rontan and its shareholders improperly terminated a Share Purchase and Sale Agreement (the “SPA”) by which we were to acquire whole ownership of Rontan. On February 5, 2018, United States District Court Southern District of Florida filed a Pretrial Scheduling Order and Order Referring Case to Mediation dated February 5, 2018 for the Company’s lawsuit against Grupo Rontan Electro Metalurgica, S.A., et al. The Case No. is 18-80106-Civ-Middlebrooks/Brannon. The court has issued a schedule outlining various documents and responses that are to be delivered by the parties as part of the discovery plan. On April 25, 2018, the Note of Filing Proposed Summons was completed by the Company. On April 26, 2018, a summons was issued to Grupo Rontan Electro Metalurgica, S.A. Also, on May 15, 2018, the Company filed a motion for Issuance of Letters Rogatory. On or about January 31, 2019, Defendants filed a Motion to Dismiss for Failure to State a Claim for failure to fulfill conditions precedent in the consummation of the contract in question. Defendants filed a Motion to Dismiss challenging jurisdiction, venue, and forum nonconvenes forum nonconvenes	NOTE 6 – COMMITMENTS AND CONTINGENCIES Legal Proceedings We may be involved in legal proceedings in the ordinary course of our business, and our management cannot predict the ultimate outcome of these legal proceedings with certainty. The Company is plaintiff or defendant in the following actions: Share Purchase and Sale Agreement for Acquisition of Grupo Rontan Electro Metalurgica, S.A. Effective October 13, 2015, the Company (as “Purchaser”) entered into the SPSA dated October 8, 2015 with Joao Alberto Bolzan and Jose Carlos Bolzan, both Brazilian residents (collectively, the “Sellers”) and Grupo Rontan Electro Metalurgica, S.A., a limited liability company duly organized and existing under the laws of Federative Republic of Brazil (“Rontan”) (collectively, the “Parties”), pursuant to which the Sellers agreed to sell 100% of the issued and outstanding shares of Rontan to the Purchaser on the closing date. The purchase price shall consist of a cash amount, a stock amount and an earn-out amount as follows: (i) Brazilian Real (“R”) $100 million (approximately US$26 million) to be paid by the Purchaser in equal monthly installments over a period of forty eight (48) months following the closing date; (ii) an aggregate of R$100 million (approximately US$26 million) in shares of the Purchaser’s common stock, valued at US$1.00 per share; and (iii) an earn-out payable within ten business days following receipt by the Purchaser of Rontan’s audited financial statements for the 12-months ended December 31, 2017, 2018 and 2019. The earn-out shall be equal to the product of (i) Rontan’s earnings before interest, taxes, depreciation and amortization (“EBITDA”) for the last 12 months, and (ii) twenty percent and is contingent upon Rontan’s EBITDA results for any earn-out period being at least 125% of Rontan’s EBITDA for the 12-months ended December 31, 2015. It is the intention of the parties that the stock amount will be used by Rontan to repay institutional debt outstanding as of the closing date. Under the terms of a Finders Fees Agreement dated April 14, 2014, we have agreed to pay RLT Consulting Inc., a related party, a fee of 2% (two percent) of the Transaction Value, as defined in the agreement, of Rontan upon closing. The fee is payable one-half in cash and one-half in shares of our common stock. Specific conditions to closing consist of: a) Purchaser’s receipt of written limited assurance of an unqualified opinion with respect to Rontan’s audited financial statements for the years ended December 31, 2013 and 2014 (the “Opinion”); b) The commitment of sufficient investment by General American Capital Partners LLC (the “Institutional Investor”), in the Purchaser following receipt of the Opinion; c) The accuracy of each Parties’ representations and warranties contained in the SPSA; d) The continued operation of Rontan’s business in the ordinary course; e) The maintenance of all of Rontan’s bank credit lines in the maximum amount of R$200 million (approximately US$52 million) under the same terms and conditions originally agreed with any such financial institutions, and the maintenance of all other types of funding arrangements. As of the date of the SPSA, Rontan’s financial institution debt consists of not more than R$200 million (approximately US$52 million), trade debt of not more than R$50 million (approximately US$13 million) and other fiscal contingencies of not more that R$95 million (approximately US$24.7 million); f) Rontan shall enter into employment or consulting service agreements with key employees and advisors identified by the Purchaser, including Rontan’s Chief Executive Officer; and g) The Sellers continued guarantee of Rontan’s bank debt for a period of 90 days following issuance of the Opinion, among other items. The Institutional Investor has committed to invest sufficient capital to facilitate the transaction, subject to receipt of the Opinion, as well as the ability to acquire 100% of the outstanding stock of Rontan at a price of $200 million BR, and the Company can acquire 100% of all real estate held by Rontan. Subject to satisfaction or waiver of the conditions precedent provided for in the SPSA, the closing date of the transaction shall take place within 10 business days from the date of issuance of the Opinion. Rontan is engaged in the manufacture and distribution of specialty vehicles and acoustic/visual signaling equipment for the industrial and automotive markets. Subsequent to December 31, 2015, on April 1, 2016, we believed that we had satisfied or otherwise waived the conditions to closing (as disclosed under the SPSA, the closing was subject to specific conditions to closing, which were waivable by us,) and advised the Sellers of our intention to close the SPSA and demanded delivery of the Rontan Securities. The Sellers, however, notified us that they intend to terminate the SPSA. We believe that the Sellers had no right to terminate the SPSA and that notice of termination by the Sellers was not permitted under the terms of the SPSA. On January 31, 2018, we announced that we initiated a lawsuit for damages against Grupo Rontan Metalurgica, S. A, (“Rontan”) and that company’s controlling shareholders, Joao Alberto Bolzan and Jose Carlos Bolzan. The action has been filed in the United States District Court for the Southern District of Florida. The complaint alleges that Rontan is wholly owned by Joao Bolzan and Jose Bolzan. In the complaint, we further allege that Rontan and its shareholders improperly terminated a Share Purchase and Sale Agreement (the “SPA”) by which we were to acquire whole ownership of Rontan. On February 5, 2018, United States District Court Southern District of Florida filed a Pretrial Scheduling Order and Order Referring Case to Mediation dated February 5, 2018, for the Company’s lawsuit against Grupo Rontan Electro Metalurgica, S.A., et al. The Case No. is 18-80106-Civ-Middlebrooks/Brannon. The court has issued a schedule outlining various documents and responses that are to be delivered by the parties as part of the discovery plan. On April 25, 2018, the Note of Filing Proposed Summons was completed by the Company. On April 26, 2018, a summons was issued to Grupo Rontan Electro Metalurgica, S.A. Also, on May 15, 2018, the Company filed a motion for Issuance of Letters Rogatory. Consulting agreements The Company entered into two consulting agreements (See Note 5) in May 2016, for services to be provided in connection towards the resolution of the Rontan lawsuit (below). The consulting agreements includes a monthly retainer payment of $10,000 to each consultant. The agreement also includes consideration of 5,000,000 shares of restricted common stock of the Company, plus a 5% cash consideration of the Resolution Progress Funding, (defined as upon the retention of legal counsel and receipt of funding for the litigation), as of the Resolution Progress Funding date and 10,000,000 shares of restricted common stock of the Company and a 5% cash consideration of the Resolution Funding amount (defined as a settlement or judgement in favor of the Company by Rotan),at the Resolution Funding date. The Resolution Progress funding was met on December 22, 2017.

STOCKHOLDERS_ EQUITY

STOCKHOLDERS’ EQUITY	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Equity [Abstract]
STOCKHOLDERS’ EQUITY	NOTE 7 – STOCKHOLDERS’ EQUITY Stock Incentive Plans 2014 Global Digital Solutions Equity Incentive Plan On May 9, 2014, our shareholders approved the 2014 Global Digital Solutions Equity Incentive Plan (“Plan”) and reserved 20,000,000 In accordance with the ACS 718, Compensation – Stock Compensation Awards Issued Under Stock Incentive Plans As of March 31, 2023, and December 31, 2022, we have outstanding 13,650,002 0.60 3.6 During the three-month period ended March 31, 2023 and the year ended December 31, 2022, we did not recognize any stock-based compensation cost related to the outstanding stock options. The intrinsic value of options outstanding as of March 31, 2023, and December 31, 2022, was $ 0	NOTE 7 – STOCKHOLDERS’ EQUITY Preferred Stock We are authorized to issue 35,000,000 0.001 1,000,000 On August 15, 2016, William J. Delgado, our current Chief Executive Officer, agreed to convert $231,565 of indebtedness owed to him by the Company into 1,000,000 shares of convertible preferred stock (the “Preferred Stock”). The Preferred Stock has voting rights as to one (1) preferred share to four hundred (400) shares of the common stock of the Company. The Preferred Stock is convertible into common stock at any time after issuance into 37% of the outstanding common stock of the Company at the time of the conversion. The conversion to common can only take place when there are an adequate number of shares that are available and is subject to normal stock adjustments (i.e. stock splits etc.) that are executed by the Company in its normal course of business. Common Stock We are authorized to issue 2,000,000,000 0.001 Common Stock Warrant We have issued warrants, which are fully vested and available for exercise, as follows: The following is a summary of outstanding and exercisable warrants at December 31, 2022: Schedule of summary of outstanding and warrants exercisable Outstanding Exercisable Weighted Average Outstanding Range of Number Remaining Weighted Number Weighted Exercise Outstanding Contractual Average Exercisable Average Prices at 12/31/2022 Life (in yrs) Exercise Price at 12/31/2022 Exercise Price $ 0.01 12,000,000 4 $ 0.01 12,000,000 $ 0.01 $ 0.01 1,000,000 4.1 $ 0.01 1,000,000 $ 0.01 $ 0.01 1,000,000 4.2 $ 0.01 1,000,000 $ 0.01 $ 0.01 1,000,000 4.3 $ 0.01 1,000,000 $ 0.01 $ 0.01 1,000,000 4.4 $ 0.01 1,000,000 $ 0.01 $ 0.01 1,000,000 4.5 $ 0.01 1,000,000 $ 0.01 $ 0.01 1,000,000 4.6 $ 0.01 1,000,000 $ 0.01 $ 0.01 1,000,000 4.7 $ 0.01 1,000,000 $ 0.01 $ 0.01 1,000,000 4.8 $ 0.01 1,000,000 $ 0.01 $ 0.01 1,000,000 4.9 $ 0.01 1,000,000 $ 0.01 $ 0.01 1,000,000 5 $ 0.01 1,000,000 $ 0.01 $ 0.01 1,000,000 5.1 $ 0.01 1,000,000 $ 0.01 $ 0.01 10,000,000 9 $ 0.01 10,000,000 $ 0.01 $ 0.01 20,000,000 8 $ 0.01 20,000,000 $ 0.01 $ 0.03 2,096,875 1 $ 0.01 2,096,875 $ 0.01 $ 0.01 10,750,000 4.8 $ 0.01 10,750,000 $ 0.01 $ 0.01 500,000 3 $ 0.01 500,000 $ 0.01 $ 0.01 100,000 3 $ 0.01 100,000 $ 0.01 66,446,875 66,446,875 All warrants are exercisable at any time through the date of expiration. All agreements provide for the number of shares to be adjusted in the event of a stock split, a reverse stock split, a share exchange or other conversion or exchange event in which case the number of warrants and the exercise price of the warrants shall be adjusted on a proportional basis. The following is a summary of outstanding and exercisable warrants at December 31, 2021: Outstanding Exercisable Weighted Average Outstanding Range of Number Remaining Weighted Number Weighted Exercise Outstanding Contractual Average Exercisable Average Prices at 12/31/2021 Life (in yrs) Exercise Price at 12/31/2021 Exercise Price $ 0.01 5,000,000 0.5 0.004 5,000,000 $ 0.01 $ 0.01 3,750,000 2.1 0.002 3,750,000 $ 0.01 $ 0.01 12,000,000 2 $ 0.01 12,000,000 $ 0.01 $ 0.01 2,500,000 2.8 $ 0.01 2,500,000 $ 0.01 $ 0.01 10,000,000 8.2 $ 0.01 10,000,000 $ 0.01 $ 0.01 20,000,000 8.3 $ 0.01 20,000,000 $ 0.01 $ 0.01 2,096,875 3.6 $ 0.01 2,096,875 $ 0.01 $ 0.01 12,000,000 5 $ 0.01 12,000,000 $ 0.01 $ 0.01 1,000,000 5.1 $ 0.01 1,000,000 $ 0.01 $ 0.01 1,000,000 5.2 $ 0.01 1,000,000 $ 0.01 $ 0.01 1,000,000 5.3 $ 0.01 1,000,000 $ 0.01 $ 0.01 1,000,000 5.4 $ 0.01 1,000,000 $ 0.01 $ 0.01 1,000,000 5.5 $ 0.01 1,000,000 $ 0.01 $ 0.01 1,000,000 5.6 $ 0.01 1,000,000 $ 0.01 $ 0.01 1,000,000 5.7 $ 0.01 1,000,000 $ 0.01 $ 0.01 1,000,000 5.8 $ 0.01 1,000,000 $ 0.01 $ 0.01 1,000,000 5.9 $ 0.01 1,000,000 $ 0.01 $ 0.01 1,000,000 5.1 $ 0.01 1,000,000 $ 0.01 $ 0.01 1,000,000 5.1 $ 0.01 1,000,000 $ 0.01 78,346,875 78,346,875 The intrinsic value of warrants outstanding at December 31, 2022, and 2021, was $0. Aggregate intrinsic value represents the value of the Company’s closing stock price on the last trading day of the fiscal period in excess of the exercise price of the warrant multiplied by the number of warrants outstanding or exercisable. Stock Incentive Plans 2014 Global Digital Solutions Equity Incentive Plan On May 9, 2014, our shareholders approved the 2014 Global Digital Solutions Equity Incentive Plan (“Plan”) and reserved 20,000,000 shares of our common stock for issuance pursuant to awards thereunder, including options, stock appreciation right, restricted stock, restricted stock units, performance awards, dividend equivalents, or other stock-based awards. The Plan is intended as an incentive, to retain in the employ of the Company, our directors, officers, employees, consultants, and advisors, and to attract new officers, employees, directors, consultants and advisors whose services are considered valuable, to encourage the sense of proprietorship and to stimulate the active interest of such persons in the development and financial success of the Company and its subsidiaries. In accordance with the ACS 718, Compensation – Stock Compensation Stock-based compensation expense for the years ended December 31, 2022, and 2021 was $0 and $5,075, respectively. Awards Issued Under Stock Incentive Plans Stock Option Activity On December 31, 2022, and 2021we have outstanding stock options of 12,900,000 and 13,650,002 respectively - all of which are fully-vested stock options that were granted to directors, officers and consultants. The outstanding stock options are exercisable at prices ranging from $0.006 to $0.64 and expire between February 2024 and December 2025, for an average exercise price per share of $0.60 and an average remaining term of 3 years as of December 31, 2022. During the years ended December 31, 2022, and 2021, we did not recognize any stock-based compensation cost related to the outstanding stock options. The intrinsic value of options outstanding at December 31, 2022, and 2021, was $0. Aggregate intrinsic value represents the value of the Company’s closing stock price on the last trading day of the fiscal period in excess of the exercise price of the option multiplied by the number of options outstanding. Restricted Stock Units On October 10, 2014, we granted an employee 1 million RSU’s convertible into 1 million shares of the Company’s common stock, with a grant date fair market value of $100,000. The grant was made under our 2014 Equity Incentive Plan. 333,333 RSU’s will vest in respect of each calendar year (commencing January 1 and ending December 31) of the Company from 2015 through 2017 if the Company has achieved at least 90% of the total revenue and EBITDA midpoint targets set forth in the agreement. If less than 90% of the target is achieved in respect of any such fiscal year, then the number of RSU’s vesting for that fiscal year shall be 333,333 times the applicable percentage set forth in the agreement; provided that, Awards Not Issued Under Stock Incentive Plans Restricted Stock Grants Awarded to Advisors In order to align our senior advisors with the interest of the stakeholders of the Company, the Board of Directors of the Company has granted the advisors restricted stock awards valued at $0.17 to $0.364 per share which vest over a period of 12 – 24 months, subject to remaining an advisor for a minimum of twelve months, and which are forfeited if the advisor is terminated or is no longer an advisor on the anniversary of the advisory award, as follows: Schedule of intrinsic value of the restricted stock grant December 31, 2022 Name Date of Number of Vest from Vest To Vested Unvested Forfeited Mathew Kelley 4/17/13 1,250,000 4/30/13 3/31/1 1,250,000 — — 4/17/13 1,250,000 2/28/14 1/31/15 1,250,000 — — Richard J. Feldman 4/30/14 500,000 4/30/14 3/30/15 500,000 — — 500,000 4/30/15 3/30/16 375,000 — 125,000 Gary Gray 3/7/15 1,000,000 3/7/15 5/30/15 1,000,000 — — Ross Trevino 3/7/15 500,000 3/7/15 5/30/15 500,000 — — 5,000,000 4,875,000 — 125,000 The aggregate intrinsic value of the restricted stock grant was $0 on December 31, 2022, and 2021.

INCOME TAXES

INCOME TAXES	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
INCOME TAXES	NOTE 8 – INCOME TAXES The Company provides for a valuation allowance when it is more likely than not that they will not realize a portion of the deferred tax assets. The Company has established a valuation allowance against their net deferred tax asset due to the uncertainty that enough taxable income will be generated in those taxing jurisdictions to utilize the assets. Therefore, they have not reflected any benefit of such deferred tax assets in the accompanying financial statements. The Company has reviewed all income tax positions taken or that are expected to be taken for all open years and determined that their income tax positions are appropriately stated and supported for all open years. The Company is subject to U.S. federal income tax examinations by tax authorities for years after 2011 due to unexpired net operating loss carryforwards originating in and subsequent to that year. The Company may be subject to income tax examinations for the various taxing authorities which vary by jurisdiction. The Company’s policy is to record interest and penalties associated with unrecognized tax benefits as additional income taxes in the consolidated statements of operations. The Company files income tax returns in the U.S. federal jurisdiction and the various states in which they operate. The former members of NACSV are required to file separate federal and state tax returns for NACSV for the periods prior to our acquisition of NACSV. The Company files consolidated tax returns for subsequent periods. The Company has not filed their U.S. federal and certain state tax returns since 2014 and currently do not have any examinations ongoing. Tax returns for the years 2012 onwards are subject to federal, state or local examinations.	NOTE 8 – INCOME TAXES Schedule of deferred tax assets and liabilities Net (Income) Loss - book $ 5,761,061 Permanent Differences: Loss on disposal of fixed assets (97,555 ) Change in warrant liability (993,000 ) Change in derivative (2,090,500 ) Debt discount amortization (1,089,902 ) Estimate loss - tax basis 1,490,104 Schedule of Reconciliations between the statutory rate and the effective tax rate 2022 Amounts Rate Income tax expense at statutory federal rate of 21% 1,210,000 21 % Permanent Differences Loss on disposal of Fixed assets (20,000 ) 0 % Change in warrant liability (209,000 ) -4 % Change in derivative (439,000 ) 8 % Debt discount amortization (229,000 ) -4 % Increase (decrease) in valuation allowance 313,000 -21 % Income tax expense (benefit) at Company’s effective tax rate $ — 0 % Schedule of Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost TOTAL Activity TOTAL 12/31/2021 2022 12/31/2022 Net Operating Loss Carryforward $ 21,774,808 $ 313,000 $ 22,087,808 NOL tax benefit $ 4,004,010 $ 313,000 $ 4,317,010 Total Deferred Tax Assets 4,004,010 313,000 4,317,010 Valuation allowance $ (4,004,010 ) $ (313,000 ) $ (4,317,010 ) $ — $ — $ — As of December 31, 2022, the Company had $ 22,087,808 The Company provides for a valuation allowance when it is more likely than not that they will not realize a portion of the deferred tax assets. The Company has established a valuation allowance against their net deferred tax asset due to the uncertainty that enough taxable income will be generated in those taxing jurisdictions to utilize the assets. Therefore, they have not reflected any benefit of such deferred tax assets in the accompanying financial statements. The Company’s net deferred tax asset and valuation allowance increased by $ 313,000 The Company has reviewed all income tax positions taken or that are expected to be taken for all open years and determined that their income tax positions are appropriately stated and supported for all open years. The Company is subject to U.S. federal income tax examinations by tax authorities for years after 2011 due to unexpired net operating loss carryforwards originating in and subsequent to that year. The Company may be subject to income tax examinations for the various taxing authorities which vary by jurisdiction. The Company’s policy is to record interest and penalties associated with unrecognized tax benefits as additional income taxes in the consolidated statements of operations. As of December 31, 2022, there were no unrecognized tax benefits, or any tax related interest or penalties. The Company files income tax returns in the U.S. federal jurisdiction and the various states in which they operate. The former members of NACSV are required to file separate federal and state tax returns for NACSV for the periods prior to our acquisition of NACSV. The Company files consolidated tax returns for subsequent periods. The Company has not filed their U.S. federal and certain state tax returns since 2014 and currently do not have any examinations ongoing. Tax returns for the years 2012 onwards are subject to federal, state or local examinations.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 9 – RELATED PARTY TRANSACTIONS Due to officer The Due to officer is due on demand, does not bear interest and is unsecured. On June 14, 2022, the CEO William J Delgado Paid a convertible note payment in the amount of $27,175 $75,218 $11,957 $3,281 Due to Related Party During the three months ended March 31, 2023 the Company advanced Eco-Growth Strategies, Inc. a related entity $42,035 $8,198 Accrued Compensation As of March 31, 2023., and December 31, 2022, we had a receivable of $23,521 $128,334 $120,834 Schedule of accrued compensation William Jerome Total Delgado Gomolski Balance December 31, 2022 $ 141,997 $ 21,163 $ 120,834 1-Q 2023 Salary 75,000 60,000 15,000 Payments, (112,184 ) (81,163 ) (7,500 ) Balance March 31, 2023 $ 128,334 $ (23,521 ) $ 128,334 Accounts Payable Schedule of accounts payable March 31, December 31, 2023 2022 RLT Consulting $ 21,591 $ 21,591 Jerry Gomolski 25,000 25,000 Charter 804CS 20,099 20,099 Gary Gray 12,000 12,000 $ 78,690 $ 78,690 During August 2017, Dragon Acquisitions, an entity owned by William Delgado, a related party, and an individual lender entered into a Promissory Note agreement for $20,000 $2,000 August 31, 2018 $22,000 December 31, 2021 22,000	NOTE 9 – RELATED PARTY TRANSACTIONS Due to officer As of December 31, 2022, the Company owes Mr. Delgado $ 21,000 During 2021 Mr.Delgado paid off approximately $ 390,000 50,000 During 2022 Mr. Delgado advance The Company $ 9,000 55,000 3,300 During the year ended December 31, 2022, The Company advanced approximately $ 140,000 . During 2022 Eco Growth repaid The Company approximately $270,000 in repayment of the current year advances, $140,000, and prior year balance of $80,000. At December 31, 2022, The Company owes Eco Growth approximately $50,000. During the year ended December 31, and 2021, the Company advanced Eco Growth Strategies, a related entity, $80,195 to cover administrative costs and legal expense. Accounts Payable Schedule of accounts payable December 31, December 31, 2022 2021 Jerry Gomolski 25,000 25,000 Charter 804CS 20,099 20,099 Gary Gray 12,000 12,000 $ 57,099 $ 57,099 Accrued Compensation On December 31, 2022, and December 31, 2021, we had $ 21,163 and $ 0 .00 payable to William J. Delgado and $ 120,834 90,834 to Jerome Gomolski, respectively. Schedule of accrued compensation William Jerome Total Delgado Gomolski Balance 12/31/2021 $ 90,834 $ 0 $ 90,834 2022 Salary 300,000 240,000 60,000 Payments (248,837 ) (218,837 ) (30,000 ) Balance 12/31/2022 $ ( 141,997 ) $ ( 21,163 ) $ ( 120,834 )

SUBSEQUENT EVENT

SUBSEQUENT EVENT	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Subsequent Events [Abstract]
SUBSEQUENT EVENT	NOTE 10 – SUBSEQUENT EVENT On April 18, 2023, Leonite Capital converted $ 139,901 10,198 .01 15,000,000	NOTE 10 – SUBSEQUENT EVENT On January 4, 2023, Company and Leonite Capital,LLC, entered into a security purchase agreement for a 8 % Convertible Note in the aggregate principal of $ 41,666 .67 less an original issue discount of $ 4,166 .67. The note shall be paid in one or more tranches. The Company received the first tranche of $21,500, on January 12, 2023. The maturity of each tranche shall be 12 months after each Tranche is advanced. The note is convertible into shares of common stock of the Company. The conversion price shall be the lower of $0.01 or the lowest trade price on the Advance Date of the first Tranche. On January 12, 2023, the Company and GS Capital Partners, LLC. entered into a security purchase agreement for a 8% 41,667 January 12, 2024 5,000,000 Schedule of Subsequent Events Date Category Description Shares Issued 1/26/2023 Settlemement Agreement The Company entered into a Settlement Agreement on January 26, 2023, with 1800 Diagonal Lending LLC f/k/a Sixth Street Lending LLC, in the amount of $550,000. The settlement agreement was set aside and a Agreed Final Order was issued on ? Pursuant to the Final order the following note balances and adjustments were made. Initial Notes entered 2/3/2022 with an initial principal amount of $103,750, adjusted to the sum of $131,096.02, plus interest at the rate of 8% from August 8, 2022, until paid. Note entered 6/14/2022 with a principal amount of $ 202,772.57 adjusted to the sum of $256,218.57, plus interest at the rate of 8 % from August 8, 2022, until paid. Note entered June 14, 2022, with an initial principal of $128,750.00 adjusted to the principal amount of $162,685.42 , plus interest at the of 8 % from August 8,2022 until paid. 2/6/2023 Promissory Note On February 6, 2023, The Company and Fourth Man, LLC entered into a Securities purchase agreement for a 12% Convertible Note in the aggregate principal of $165,000.00 less an original issue discount of $16,500.00. The note will mature in 12 months from the issue date. The note in convertible into shares of common stock on the Company at a price of $0.01. The Company shall issue 8,250,000 warrants shares at an exercise price of $0.01 and an exercise period of five years from the issue date. 2/7/2023 Notice of Conversion On February 7,2023, GS Capital Partners, LLC. converted $53,474.63 of principal and $13,885.82 of interest for 6,736,045 shares of common stock. 6,736,045 2/8/2023 Notice of Conversion On February 8, 2023 Leonite Capital LLC converted $100,000 of principal, interest, and fees for 10,000,000 shares of common stock. 10,000,000 2/21/2023 Notice of Conversion On February 21, 2023 Leonite Capital LLC converted $150,000 of principal and interest for 15,000,000 shares of common stock. 15,000,000 2/23/2023 Notice of Conversion On February 23,2023, GS Capital Partners, LLC. converted $65,000.00 of principal and $17,277.53 of interest for 8,277,753 shares of common stock. 8,227,753 3/1/2023 Notice of Conversion On March I, 2023 Leonite Capital LLC converted $200,000 of principal and interest for 20,000,000 shares of common 20,000,000 3/7/2023 Notice of Conversion On March 7,2023, GS Capital Partners, LLC. converted $80,000.00 of principal and $21,632.88 of interest for 10,163,288 shares of common stock. 10,163,288 3/17/2023 Notice of Conversion On March 17, 2023, GS Capital Partners, LLC. converted $85,000 of principal and $23,310.96 of interest for 10,831,096, shares of common stock. 10,831,096 3/22/2023 Second Amendment to Senior Secured Convertible Promissory Note Amended June 30, 2023, the Company entered into a second amendment to senior secured convertible promissory note, with Leonite Capital LLC 4/18/2023 Notice of Conversion On April 18, 2023, Leonite Capital LLC converted $150,000 of principal and interest for 15,000,000 shares of common 15,000,000 3/17/2023 Notice of Conversion On March 17, 2023, Leonite Capital LLC converted $200,000 of principal and interest for 20,000,000 shares of common 20,000,000 — 115,958,182 798,168,896 115,958,182 914,127,078

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited financial information as of and for the three months ended March 31, 2023, and 2022 has been prepared in accordance with accounting principles generally accepted in the U.S. for interim financial information and with the instructions to Quarterly Report on Form 10-Q and Article 10 of Regulation S-X. In the opinion of management, such financial information includes all adjustments (consisting only of normal recurring adjustments, unless otherwise indicated) considered necessary for a fair presentation of our financial position at such date and the operating results and cash flows for such periods. Operating results for the three months ended March 31, 2023, are not necessarily indicative of the results that may be expected for the entire year or for any other subsequent interim period. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been omitted pursuant to the rules of the U.S. Securities and Exchange Commission, or the SEC. These unaudited financial statements and related notes should be read in conjunction with our Annual Report on Form 10-K that includes the audited financial statements for the year ended December 31, 2022, as filed with the SEC on April 20, 2022. The condensed consolidated balance sheet at December 31, 2022, has been derived from the audited financial statements at that date but does not include all the information and footnotes required by generally accepted accounting principles in the U.S. for complete financial statements.
Principles of Consolidation	Principles of Consolidation The accompanying consolidated financial statements include the accounts of the Company and our wholly owned subsidiaries, NACSV, GDSI Florida, LLC, Global Digital Solutions, LLC, and Harm Alarm. All intercompany accounts and transactions have been eliminated in consolidation.	Principles of Consolidation The accompanying consolidated financial statements include the accounts of the Company and our wholly owned subsidiaries, NACSV, GDSI Florida, LLC, Global Digital Solutions, LLC and HarmAlarm. All intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, equity-based transactions, and disclosure of contingent liabilities at the date of the financial statements and revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company believes the following critical accounting policies affect its more significant judgments and estimates used in the preparation of the financial statements. Significant estimates include the derivative liability valuation, deferred tax asset and valuation allowance, and assumptions used in Black-Scholes-Merton, or BSM, or other valuation methods, such as expected volatility, risk-free interest rate, and expected dividend rate.	Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, equity-based transactions and disclosure of contingent liabilities at the date of the financial statements and revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company believes the following critical accounting policies affect its more significant judgments and estimates used in the preparation of the financial statements. Significant estimates include the derivative liability valuation, deferred tax asset and valuation allowance, and assumptions used in Black-Scholes-Merton, or BSM, or other valuation methods, such as expected volatility, risk-free interest rate, and expected dividend rate.
Income Taxes	Income Taxes Income taxes are accounted for based upon an asset and liability approach. Accordingly, deferred tax assets and liabilities arise from the difference between the tax basis of an asset or liability and its reported amount in the financial statements. Deferred tax amounts are determined using the tax rates expected to be in effect when the taxes will be paid or refunds received, as provided under currently enacted tax law. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. Income tax expense or benefit is the tax payable or refundable, respectively, for the period plus or minus the change in deferred tax assets and liabilities during the period. Accounting guidance requires the recognition of a financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement with the relevant tax authority. The Company believes its income tax filing positions and deductions will be sustained upon examination and accordingly, no reserves, or related accruals for interest and penalties have been recorded at March 31, 2023, and December 31, 2022. The Company recognizes interest and penalties on unrecognized tax benefits as well as interest received from favorable tax settlements within income tax expense.	Income Taxes Income taxes are accounted for based upon an asset and liability approach. Accordingly, deferred tax assets and liabilities arise from the difference between the tax basis of an asset or liability and its reported amount in the financial statements. Deferred tax amounts are determined using the tax rates expected to be in effect when the taxes will actually be paid or refunds received, as provided under currently enacted tax law. Valuation allowances are, when necessary, to reduce deferred tax assets to the amount expected to be realized. Income tax expense or benefit is the tax payable or refundable, respectively, for the period plus or minus the change in deferred tax assets and liabilities during the period. Accounting guidance requires the recognition of a financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit. For tax positions meeting the more-likely-than-not threshold, the amount recognized in the financial statements is the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement with the relevant tax authority. The Company believes its income tax filing positions and deductions will be sustained upon examination and accordingly, no reserves, or related accruals for interest and penalties have been recorded at December 31, 2022, and 2021 The Company recognizes interest and penalties on unrecognized tax benefits as well as interest received from favorable tax settlements within income tax expense. On December 22, 2017, the President of the United States signed and enacted into law H.R. 1 (the “Tax Reform Law”). The Tax Reform Law, effective for tax years beginning on or after January 1, 2018, except for certain provisions, resulted in significant changes to existing United States tax law, including various provisions that are expected to impact the Company. The Tax Reform Law reduces the federal corporate tax rate from 34% to 21% effective January 1, 2018. The Company analyzed the provisions of the Tax Reform Law to assess the impact on the Company’s consolidated financial statements and determined it had no material impact.
Cash and Cash Equivalents	Cash and Cash Equivalents We consider all highly liquid investments with original maturities of three months or less to be cash equivalents. We maintain our cash in high-quality financial institutions. The balances, at times, may exceed federally insured limits. As of March 31, 2023, the bank balance is not over the federally insured limit. As of March 31, 2023 and December 31, 2022, we had no	Cash and Cash Equivalents We consider all highly liquid investments with original maturities of three months or less to be cash equivalents.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The carrying value of cash, accounts payable and accrued expenses approximate their fair values based on the short-term maturity of these instruments. The carrying amounts of debt were also estimated to approximate fair value. The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement). This fair value measurement framework applies at both initial and subsequent measurement. The three levels of the fair value hierarchy defined by ASC 820 are as follows: ● Level 1 – Quoted prices in active markets for identical assets or liabilities ● Level 2 – Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable, either directly or indirectly ● Level 3 – Significant unobservable inputs that cannot be corroborated by market data.	Fair Value of Financial Instruments The carrying value of cash, accounts payable and accrued expenses approximate their fair values based on the short-term maturity of these instruments. The carrying amounts of debt were also estimated to approximate fair value. The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. ASC 820 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement). This fair value measurement framework applies at both initial and subsequent measurement. The three levels of the fair value hierarchy defined by ASC 820 are as follows: ● Level 1 – Quoted prices in active markets for identical assets or liabilities ● Level 2 – Quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable, either directly or indirectly ● Level 3 – Significant unobservable inputs that cannot be corroborated by market data.
Derivative Financial Instruments	Derivative Financial Instruments We account for conversion options embedded in convertible notes payable in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standard Codification (“ASC’) 815, “Derivatives and Hedging” Embedded Derivatives Derivative Liabilities Derivatives and Hedging – Contracts in Entity’s own Equity Change in fair value of derivative liability	Derivative Financial Instruments We account for conversion options embedded in convertible notes payable in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standard Codification (“ASC’) 815, “Derivatives and Hedging” Embedded Derivatives Derivative Liabilities Derivatives and Hedging – Contracts in Entity’s own Equity Change in fair value of derivative liability
Earnings (Loss) Per Share (“EPS”)	Earnings (Loss) Per Share (“EPS”) Basic EPS is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding. Diluted EPS includes the effect from potential issuance of common stock, such as stock issuable pursuant to the exercise of stock options and warrants and the assumed conversion of convertible notes. The following table summarizes the securities that were excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive: Securities excluded from the diluted per share calculation Three Months Ended March 31, 2023 2022 Convertible notes and accrued interest 453,945,414 406,572,394 Preferred Stock 296,201,242 255,284,000 Stock options 13,650,002 13,650,002 Warrants 78,346,875 56,096,875 Potentially dilutive securities 847,937,711 731,603,271	Earnings (Loss) Per Share (“EPS”) Basic EPS is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding. Diluted EPS includes the effect from potential issuance of common stock, such as stock issuable pursuant to the exercise of stock options and warrants and the assumed conversion of convertible notes. The following table summarizes the securities that were excluded from the diluted per share calculation because the effect of including these potential shares was antidilutive: Securities excluded from the diluted per share calculation Year Ended December 31, December 31, 2022 2021 Convertible notes and accrued interest 268,563,014 361,265,001 Preferred Stock 296,201,242 227,787,627 Stock options 12,900,000 12,900,000 Warrants 66,446,875 81,346,875 Potentially dilutive securities 644,111,131 683,299,503
Stock Based Compensation	Stock Based Compensation In accordance with ASC 718, “Compensation – Stock Compensation” the Company measures the cost of employee services received in exchange for share-based compensation measured at the grant date fair value of the award. The Company’s accounting policy for equity instruments issued to advisors, consultants, and vendors in exchange for goods and services follows the provisions of FASB ASC 505-50 .	Stock Based Compensation In accordance with ASC 718, “Compensation – Stock Compensation” the Company measures the cost of employee services received in exchange for share-based compensation measured at the grant date fair value of the award. The Company’s accounting policy for equity instruments issued to advisors, consultants, and vendors in exchange for goods and services follows the provisions of FASB ASC 505-50 . Schedule of warranty liability Warrant liability 2022 2021 Warrant Liability balance at beginning of period 606,000 560,000 Additions to warrant liability — (1,736,000 ) Change in fair value 993,000 1,782,000 Balance at end of period 1,599,000 606,000 At December 31,2022 the fair Value of the warrant liability was estimated using a Black Scholes model with the following weighted-average inputs: the price of the Company’s Common stock of $ 0.0249 3.0% 173.54% 185.9% 205.9%
Convertible Instruments	Convertible Instruments The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with accounting standards for “Accounting for Derivative Instruments and Hedging Activities.” Accounting standards generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur, and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. accounting standards also provide an exception to this rule when the host instrument is deemed to be conventional as defined under professional standards as “The Meaning of Conventional Convertible Debt Instrument.” The Company accounts for convertible instruments (when it has determined that the embedded conversion options should not be bifurcated from their host instruments) in accordance with professional standards when “Accounting for Convertible Securities with Beneficial Conversion Features,” as those professional standards pertain to “Certain Convertible Instruments.” Accordingly, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Original issue discounts (“OID”) under these arrangements are amortized over the term of the related debt to their earliest date of redemption. The Company also records when necessary deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. ASC 815-40 provides that, among other things, generally, if an event is not within the entity’s control could or require net cash settlement, then the contract shall be classified as an asset or a liability.	Convertible Instruments The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with accounting standards for “Accounting for Derivative Instruments and Hedging Activities.” Accounting standards generally provides three criteria that, if met, require companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments. These three criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur, and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. Professional standards also provide an exception to this rule when the host instrument is deemed to be conventional as defined under professional standards as “The Meaning of Conventional Convertible Debt Instrument.” The Company accounts for convertible instruments (when it has determined that the embedded conversion options should not be bifurcated from their host instruments) in accordance with professional standards when “Accounting for Convertible Securities with Beneficial Conversion Features,” as those professional standards pertain to “Certain Convertible Instruments.” Accordingly, the Company records, when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Original issue discounts (“OID”) under these arrangements are amortized over the term of the related debt to their earliest date of redemption. The Company also records when necessary deemed dividends for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. ASC 815-40 provides that, among other things, generally, if an event is not within the entity’s control could or require net cash settlement, then the contract shall be classified as an asset or a liability.
Convertible Securities	Convertible Securities Based upon ASC 815-15, we have adopted a sequencing approach regarding the application of ASC 815-40 to convertible securities. We will evaluate our contracts based upon the earliest issuance date. In the event partial reclassification of contracts subject to ASC 815-40-25 is necessary, due to our inability to demonstrate we have sufficient shares authorized and unissued, shares will be allocated on the basis of issuance date, with the earliest issuance date receiving first allocation of shares. If a reclassification of an instrument were required, it would result in the instrument issued latest being reclassified first.	Convertible Securities Based upon ASC 815-15, we have adopted a sequencing approach regarding the application of ASC 815-40 to convertible securities. We will evaluate our contracts based upon the earliest issuance date. In the event partial reclassification of contracts subject to ASC 815-40-25 is necessary, due to our inability to demonstrate we have sufficient shares authorized and unissued, shares will be allocated on the basis of issuance date, with the earliest issuance date receiving first allocation of shares. If a reclassification of an instrument were required, it would result in the instrument issued latest being reclassified first.
Recent Accounting Pronouncements	Recent Accounting Pronouncements Management is evaluating the new accounting pronouncements but does not expect them to have material impact on our financial position or results of operations.
Management’s Evaluation of Subsequent Events	Management’s Evaluation of Subsequent Events The Company evaluates events that have occurred after the balance sheet date of March 31, 2023, through the date which the financial statements were issued. Based upon the review, other than described in Note 12 – Subsequent Events, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the financial statements.
Going Concern		Going Concern The accompanying financial statements have been prepared assuming we will continue as a going concern, which contemplates the realization of assets and the liquidation of liabilities in the normal course of business. We have sustained losses and experienced negative cash flows from operations since inception, for the current year ended December 31, 2022, which we had a net loss of $ 5,761,061 used net cash of $ 523,125 to fund operating activities. On December 31, 2022, we had cash of $ 1,043 an accumulated deficit of $ 55,110,636 a working capital deficit of $ 16,076,425 16,075,382 . We have funded our activities to date almost exclusively from equity and debt financings. Our cash position is critically deficient, and payments essential to our ability to operate are not being made in the ordinary course. Failure to raise capital in the coming days to fund our operations and failure to generate positive cash flow to fund such operations in the future will have a material adverse effect on our financial condition. These factors raise substantial doubt about our ability to continue as a going concern. We need to raise additional funds immediately and continue to raise funds until we begin to generate sufficient cash from operations, and we may not be able to obtain the necessary financing on acceptable terms, or at all. We will continue to require substantial funds to continue development of our core business. Management’s plans in order to meet our operating cash flow requirements include financing activities such as private placements of common stock, and issuances of debt and convertible debt instruments, and the establishment of strategic relationships which we expect will lead to the generation of additional revenue or acquisition opportunities. While we believe that we will be successful in obtaining the necessary financing to fund our operations, there are no assurances that such additional funding will be achieved or that we will succeed in our future operations. Our ability to achieve and maintain profitability and positive cash flow is dependent upon our ability to successfully execute the plans to pursue acquisitions and raise the funds necessary to complete such acquisitions. The outcome of these matters cannot be predicted at this time. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern.
Prepaid expenses		Prepaid expenses In 2021 management reassessed the viability of testing the PALS system in house. Management reviewed at alternative choices and decided that in house testing was no longer feasible and will outsource the Pals system testing. As a result of this management decision the prepaid expense was written off and the Company incurred a loss on the write off of $315,000, and $205,000 was charged to Mr. Delgado accrued compensation and Due to officer accounts.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Accounting Policies [Abstract]
Securities excluded from the diluted per share calculation	Securities excluded from the diluted per share calculation Three Months Ended March 31, 2023 2022 Convertible notes and accrued interest 453,945,414 406,572,394 Preferred Stock 296,201,242 255,284,000 Stock options 13,650,002 13,650,002 Warrants 78,346,875 56,096,875 Potentially dilutive securities 847,937,711 731,603,271	Securities excluded from the diluted per share calculation Year Ended December 31, December 31, 2022 2021 Convertible notes and accrued interest 268,563,014 361,265,001 Preferred Stock 296,201,242 227,787,627 Stock options 12,900,000 12,900,000 Warrants 66,446,875 81,346,875 Potentially dilutive securities 644,111,131 683,299,503
Schedule of warranty liability	Schedule of fair value derivative liabilities March 31, December 31, Warrant liability: Balance at beginning of period $ 1,599,000 $ 606,000 Additions - - Change in fair value (851,000 ) ( 993,000 ) Balance at end of year $ 748,000 $ 1,599,000	Schedule of warranty liability Warrant liability 2022 2021 Warrant Liability balance at beginning of period 606,000 560,000 Additions to warrant liability — (1,736,000 ) Change in fair value 993,000 1,782,000 Balance at end of period 1,599,000 606,000

ACCRUED EXPENSES (Tables)

ACCRUED EXPENSES (Tables)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Payables and Accruals [Abstract]
Schedule of Accrued Expenses	Schedule of accrued expenses March 31, December 31, Accrued compensation to executive officers $ 128,334 141,997 Accrued professional fees and settlements 55,163 73,890 Accrued interest 1,809,541 1,812,914 Total accrued expenses $ 1,993,038 $ 2,028,801	Schedule of Accrued Expenses December 31, December 31, 2022 2021 Accrued compensation to executive officers $ 141,997 $ 90,834 Accrued professional fees and settlements 73,890 86,392 Accrued interest 1,812,914 1,304,684 Total accrued expenses $ 2,028,801 $ 1,481,910

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Fair Value Disclosures [Abstract]
Schedule of Fair Value of Liabilities	Schedule of fair value derivative liabilities March 31, December 31, Derivative liability: Balance at beginning of period $ 3,421,000 $ 809,000 Additions 245,000 641,500 Settlements (511,000 ) (120,000 ) Change in fair value (1,136,000 ) 2,090,500 Balance at end of year $ 2,019,000 $ 3,421,000	Schedule of Fair Value of Liabilities Balance at beginning of period $ 809,000 $ 9,367,159 Additions 641,500 266,000 Settlements (120,000 ) (1,580,000 ) Change in fair value 2,090,500 (7,244,159 ) Balance at end of year $ 3,421,000 $ 809,000
Schedule of fair value derivative liabilities	Schedule of fair value derivative liabilities March 31, December 31, Warrant liability: Balance at beginning of period $ 1,599,000 $ 606,000 Additions - - Change in fair value (851,000 ) ( 993,000 ) Balance at end of year $ 748,000 $ 1,599,000	Schedule of warranty liability Warrant liability 2022 2021 Warrant Liability balance at beginning of period 606,000 560,000 Additions to warrant liability — (1,736,000 ) Change in fair value 993,000 1,782,000 Balance at end of period 1,599,000 606,000

RELATED PARTY TRANSACTIONS (Tab

RELATED PARTY TRANSACTIONS (Tables)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Related Party Transactions [Abstract]
Schedule of accrued compensation	Schedule of accrued compensation William Jerome Total Delgado Gomolski Balance December 31, 2022 $ 141,997 $ 21,163 $ 120,834 1-Q 2023 Salary 75,000 60,000 15,000 Payments, (112,184 ) (81,163 ) (7,500 ) Balance March 31, 2023 $ 128,334 $ (23,521 ) $ 128,334	Schedule of accrued compensation William Jerome Total Delgado Gomolski Balance 12/31/2021 $ 90,834 $ 0 $ 90,834 2022 Salary 300,000 240,000 60,000 Payments (248,837 ) (218,837 ) (30,000 ) Balance 12/31/2022 $ ( 141,997 ) $ ( 21,163 ) $ ( 120,834 )
Schedule of accounts payable	Schedule of accounts payable March 31, December 31, 2023 2022 RLT Consulting $ 21,591 $ 21,591 Jerry Gomolski 25,000 25,000 Charter 804CS 20,099 20,099 Gary Gray 12,000 12,000 $ 78,690 $ 78,690	Schedule of accounts payable December 31, December 31, 2022 2021 Jerry Gomolski 25,000 25,000 Charter 804CS 20,099 20,099 Gary Gray 12,000 12,000 $ 57,099 $ 57,099
Schedule of summary of outstanding and warrants exercisable		Schedule of summary of outstanding and warrants exercisable Outstanding Exercisable Weighted Average Outstanding Range of Number Remaining Weighted Number Weighted Exercise Outstanding Contractual Average Exercisable Average Prices at 12/31/2022 Life (in yrs) Exercise Price at 12/31/2022 Exercise Price $ 0.01 12,000,000 4 $ 0.01 12,000,000 $ 0.01 $ 0.01 1,000,000 4.1 $ 0.01 1,000,000 $ 0.01 $ 0.01 1,000,000 4.2 $ 0.01 1,000,000 $ 0.01 $ 0.01 1,000,000 4.3 $ 0.01 1,000,000 $ 0.01 $ 0.01 1,000,000 4.4 $ 0.01 1,000,000 $ 0.01 $ 0.01 1,000,000 4.5 $ 0.01 1,000,000 $ 0.01 $ 0.01 1,000,000 4.6 $ 0.01 1,000,000 $ 0.01 $ 0.01 1,000,000 4.7 $ 0.01 1,000,000 $ 0.01 $ 0.01 1,000,000 4.8 $ 0.01 1,000,000 $ 0.01 $ 0.01 1,000,000 4.9 $ 0.01 1,000,000 $ 0.01 $ 0.01 1,000,000 5 $ 0.01 1,000,000 $ 0.01 $ 0.01 1,000,000 5.1 $ 0.01 1,000,000 $ 0.01 $ 0.01 10,000,000 9 $ 0.01 10,000,000 $ 0.01 $ 0.01 20,000,000 8 $ 0.01 20,000,000 $ 0.01 $ 0.03 2,096,875 1 $ 0.01 2,096,875 $ 0.01 $ 0.01 10,750,000 4.8 $ 0.01 10,750,000 $ 0.01 $ 0.01 500,000 3 $ 0.01 500,000 $ 0.01 $ 0.01 100,000 3 $ 0.01 100,000 $ 0.01 66,446,875 66,446,875 All warrants are exercisable at any time through the date of expiration. All agreements provide for the number of shares to be adjusted in the event of a stock split, a reverse stock split, a share exchange or other conversion or exchange event in which case the number of warrants and the exercise price of the warrants shall be adjusted on a proportional basis. The following is a summary of outstanding and exercisable warrants at December 31, 2021: Outstanding Exercisable Weighted Average Outstanding Range of Number Remaining Weighted Number Weighted Exercise Outstanding Contractual Average Exercisable Average Prices at 12/31/2021 Life (in yrs) Exercise Price at 12/31/2021 Exercise Price $ 0.01 5,000,000 0.5 0.004 5,000,000 $ 0.01 $ 0.01 3,750,000 2.1 0.002 3,750,000 $ 0.01 $ 0.01 12,000,000 2 $ 0.01 12,000,000 $ 0.01 $ 0.01 2,500,000 2.8 $ 0.01 2,500,000 $ 0.01 $ 0.01 10,000,000 8.2 $ 0.01 10,000,000 $ 0.01 $ 0.01 20,000,000 8.3 $ 0.01 20,000,000 $ 0.01 $ 0.01 2,096,875 3.6 $ 0.01 2,096,875 $ 0.01 $ 0.01 12,000,000 5 $ 0.01 12,000,000 $ 0.01 $ 0.01 1,000,000 5.1 $ 0.01 1,000,000 $ 0.01 $ 0.01 1,000,000 5.2 $ 0.01 1,000,000 $ 0.01 $ 0.01 1,000,000 5.3 $ 0.01 1,000,000 $ 0.01 $ 0.01 1,000,000 5.4 $ 0.01 1,000,000 $ 0.01 $ 0.01 1,000,000 5.5 $ 0.01 1,000,000 $ 0.01 $ 0.01 1,000,000 5.6 $ 0.01 1,000,000 $ 0.01 $ 0.01 1,000,000 5.7 $ 0.01 1,000,000 $ 0.01 $ 0.01 1,000,000 5.8 $ 0.01 1,000,000 $ 0.01 $ 0.01 1,000,000 5.9 $ 0.01 1,000,000 $ 0.01 $ 0.01 1,000,000 5.1 $ 0.01 1,000,000 $ 0.01 $ 0.01 1,000,000 5.1 $ 0.01 1,000,000 $ 0.01 78,346,875 78,346,875
Schedule of intrinsic value of the restricted stock grant		Schedule of intrinsic value of the restricted stock grant December 31, 2022 Name Date of Number of Vest from Vest To Vested Unvested Forfeited Mathew Kelley 4/17/13 1,250,000 4/30/13 3/31/1 1,250,000 — — 4/17/13 1,250,000 2/28/14 1/31/15 1,250,000 — — Richard J. Feldman 4/30/14 500,000 4/30/14 3/30/15 500,000 — — 500,000 4/30/15 3/30/16 375,000 — 125,000 Gary Gray 3/7/15 1,000,000 3/7/15 5/30/15 1,000,000 — — Ross Trevino 3/7/15 500,000 3/7/15 5/30/15 500,000 — — 5,000,000 4,875,000 — 125,000
Schedule of deferred tax assets and liabilities		Schedule of deferred tax assets and liabilities Net (Income) Loss - book $ 5,761,061 Permanent Differences: Loss on disposal of fixed assets (97,555 ) Change in warrant liability (993,000 ) Change in derivative (2,090,500 ) Debt discount amortization (1,089,902 ) Estimate loss - tax basis 1,490,104
Schedule of Reconciliations between the statutory rate and the effective tax rate		Schedule of Reconciliations between the statutory rate and the effective tax rate 2022 Amounts Rate Income tax expense at statutory federal rate of 21% 1,210,000 21 % Permanent Differences Loss on disposal of Fixed assets (20,000 ) 0 % Change in warrant liability (209,000 ) -4 % Change in derivative (439,000 ) 8 % Debt discount amortization (229,000 ) -4 % Increase (decrease) in valuation allowance 313,000 -21 % Income tax expense (benefit) at Company’s effective tax rate $ — 0 %
Schedule of Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost		Schedule of Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost TOTAL Activity TOTAL 12/31/2021 2022 12/31/2022 Net Operating Loss Carryforward $ 21,774,808 $ 313,000 $ 22,087,808 NOL tax benefit $ 4,004,010 $ 313,000 $ 4,317,010 Total Deferred Tax Assets 4,004,010 313,000 4,317,010 Valuation allowance $ (4,004,010 ) $ (313,000 ) $ (4,317,010 ) $ — $ — $ —
Schedule of Subsequent Events		Schedule of Subsequent Events Date Category Description Shares Issued 1/26/2023 Settlemement Agreement The Company entered into a Settlement Agreement on January 26, 2023, with 1800 Diagonal Lending LLC f/k/a Sixth Street Lending LLC, in the amount of $550,000. The settlement agreement was set aside and a Agreed Final Order was issued on ? Pursuant to the Final order the following note balances and adjustments were made. Initial Notes entered 2/3/2022 with an initial principal amount of $103,750, adjusted to the sum of $131,096.02, plus interest at the rate of 8% from August 8, 2022, until paid. Note entered 6/14/2022 with a principal amount of $ 202,772.57 adjusted to the sum of $256,218.57, plus interest at the rate of 8 % from August 8, 2022, until paid. Note entered June 14, 2022, with an initial principal of $128,750.00 adjusted to the principal amount of $162,685.42 , plus interest at the of 8 % from August 8,2022 until paid. 2/6/2023 Promissory Note On February 6, 2023, The Company and Fourth Man, LLC entered into a Securities purchase agreement for a 12% Convertible Note in the aggregate principal of $165,000.00 less an original issue discount of $16,500.00. The note will mature in 12 months from the issue date. The note in convertible into shares of common stock on the Company at a price of $0.01. The Company shall issue 8,250,000 warrants shares at an exercise price of $0.01 and an exercise period of five years from the issue date. 2/7/2023 Notice of Conversion On February 7,2023, GS Capital Partners, LLC. converted $53,474.63 of principal and $13,885.82 of interest for 6,736,045 shares of common stock. 6,736,045 2/8/2023 Notice of Conversion On February 8, 2023 Leonite Capital LLC converted $100,000 of principal, interest, and fees for 10,000,000 shares of common stock. 10,000,000 2/21/2023 Notice of Conversion On February 21, 2023 Leonite Capital LLC converted $150,000 of principal and interest for 15,000,000 shares of common stock. 15,000,000 2/23/2023 Notice of Conversion On February 23,2023, GS Capital Partners, LLC. converted $65,000.00 of principal and $17,277.53 of interest for 8,277,753 shares of common stock. 8,227,753 3/1/2023 Notice of Conversion On March I, 2023 Leonite Capital LLC converted $200,000 of principal and interest for 20,000,000 shares of common 20,000,000 3/7/2023 Notice of Conversion On March 7,2023, GS Capital Partners, LLC. converted $80,000.00 of principal and $21,632.88 of interest for 10,163,288 shares of common stock. 10,163,288 3/17/2023 Notice of Conversion On March 17, 2023, GS Capital Partners, LLC. converted $85,000 of principal and $23,310.96 of interest for 10,831,096, shares of common stock. 10,831,096 3/22/2023 Second Amendment to Senior Secured Convertible Promissory Note Amended June 30, 2023, the Company entered into a second amendment to senior secured convertible promissory note, with Leonite Capital LLC 4/18/2023 Notice of Conversion On April 18, 2023, Leonite Capital LLC converted $150,000 of principal and interest for 15,000,000 shares of common 15,000,000 3/17/2023 Notice of Conversion On March 17, 2023, Leonite Capital LLC converted $200,000 of principal and interest for 20,000,000 shares of common 20,000,000 — 115,958,182 798,168,896 115,958,182 914,127,078

DESCRIPTION OF BUSINESS (Detail

DESCRIPTION OF BUSINESS (Details Narrative) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Net Loss	$ 590,000
Change in fair value of derivative liability	1,136,000
Warrant Liability	851,000
Gain on conversion of notes payable	75,300
Amortization of original issue discount	216,000
Interest expense	266,000
Net cash used in operating activities	179,923	$ 119,773	$ 523,125	$ 2,639,564
Accumulated deficit	54,520,000
Working capital deficit	$ 13,212,000		$ 16,076,425

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - shares	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Dec. 31, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities	847,937,711	731,603,271	644,111,131	683,299,503
Convertible Notes Payable [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities	453,945,414	406,572,394	268,563,014	361,265,001
Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities	296,201,242	255,284,000	296,201,242	227,787,627
Equity Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities	13,650,002	13,650,002	12,900,000	12,900,000
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potentially dilutive securities	78,346,875	56,096,875	66,446,875	81,346,875

SUMMARY OF SIGNIFICANT ACCOUN_5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Accounting Policies [Abstract]
Cash equivalents	$ 0		$ 0
Net loss	(589,697)	$ 930,083	5,761,061	$ (2,211,309)
Operating activities			523,125
Cash	1,585		1,043	98,800
Accumulated deficit	54,520,939		55,110,636	49,349,575
Working capital deficit	13,212,000		16,076,425
Stockholders' deficit	$ 13,211,697		$ 16,075,382	$ 11,060,927	$ 16,805,460
Share price	$ 0.05		$ 0.0249
Risk free interest rate			3%
Volatility			173.54%
Warrant issuance percentage			185.90%	205.90%

ACCRUED EXPENSES (Details)

ACCRUED EXPENSES (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Payables and Accruals [Abstract]
Accrued compensation to executive officers	$ 128,334	$ 141,997	$ 90,834
Accrued professional fees and settlements	55,163	73,890	86,392
Accrued interest	1,809,541	1,812,914	1,304,684
Total accrued expenses	$ 1,993,038	$ 2,028,801	$ 1,481,910

FAIR VALUE MEASUREMENTS (Detail

FAIR VALUE MEASUREMENTS (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Balance at beginning of period	$ 3,421,000	$ 809,000
Additions	245,000	641,500
Settlements	(511,000)	(120,000)
Change in fair value	(1,136,000)	2,090,500
Balance at end of year	2,019,000	3,421,000	$ 809,000
Derivative [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Balance at beginning of period	$ 3,421,000	809,000	9,367,159
Additions		641,500	266,000
Settlements		(120,000)	(1,580,000)
Change in fair value		2,090,500	(7,244,159)
Balance at end of year		$ 3,421,000	$ 809,000

FAIR VALUE MEASUREMENTS (Deta_2

FAIR VALUE MEASUREMENTS (Details 1) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Fair Value Disclosures [Abstract]
Balance at beginning of period	$ 1,599,000	$ 606,000
Additions
Change in fair value	(851,000)	993,000	$ 1,782,000
Balance at end of period	$ 748,000	$ 1,599,000	$ 606,000

FAIR VALUE MEASUREMENTS (Deta_3

FAIR VALUE MEASUREMENTS (Details Narrative) - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Share Price	$ 0.05	$ 0.0249
Risk free interest rate		4.73%	0.08%
Volatility		173.74%
Dividend rate	0%	0%	173.74%
Term		1 year	3 months 21 days
Minimum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Risk free interest rate	4.50%
Volatility	173.74%
Maximum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Risk free interest rate	5%
Volatility	185.90%

NOTE PAYABLE (Details Narrative

NOTE PAYABLE (Details Narrative) - USD ($)

1 Months Ended

12 Months Ended

Mar. 07, 2023

Feb. 07, 2023

Feb. 06, 2023

Jan. 04, 2023

Dec. 14, 2022

Nov. 07, 2022

Jun. 14, 2022

Feb. 03, 2022

Dec. 10, 2021

Jun. 07, 2021

Aug. 05, 2020

May 12, 2020

Apr. 07, 2020

Apr. 06, 2020

May 10, 2019

Mar. 17, 2023

Feb. 23, 2023

Aug. 18, 2022

Apr. 21, 2022

Mar. 25, 2022

Mar. 25, 2021

Feb. 25, 2021

Aug. 17, 2020

May 20, 2020

Aug. 31, 2018

Jun. 30, 2018

May 31, 2018

Apr. 30, 2018

Dec. 26, 2017

Dec. 23, 2017

Aug. 31, 2017

Aug. 31, 2017

Jan. 31, 2015

Dec. 31, 2022

Dec. 31, 2021

Mar. 31, 2023

Dec. 22, 2017

Debt Instrument [Line Items]

Accrued interest

$ 1,812,914

$ 1,304,684

$ 1,809,541

Repayments of notes payable

125,000

Leonite Capital LLC [Member] | Security Purchase Agreement [Member]

Debt Instrument [Line Items]

Principal amount

$ 41,667

Interest rate

8%

PPP [Member]

Debt Instrument [Line Items]

Principal amount

$ 103,125

Interest rate

1%

William Delgado [Member]

Debt Instrument [Line Items]

Principal amount

$ 20,000

$ 20,000

Accrued interest

$ 2,000

$ 2,000

Notes payable

$ 22,000

20,000

20,000

20,000

Maturity date

Dec. 31, 2021

Aug. 31, 2018

Dec. 31, 2022

Parabellum [Member]

Debt Instrument [Line Items]

Principal amount

$ 2,550,000

Notes payable

2,550,000

2,550,000

Vox [Member]

Debt Instrument [Line Items]

Principal amount

$ 485,000

Accrued interest

290,813

290,813

Notes payable

861,500

926,500

861,500

Interest rate

7%

Consulting fees

120,000

:RLT [Member]

Debt Instrument [Line Items]

Principal amount

$ 485,000

Accrued interest

290,513

290,513

Notes payable

861,500

$ 919,500

861,500

Interest rate

7%

Consulting fees

120,000

Third Party Vendor [Member]

Debt Instrument [Line Items]

Notes payable

$ 36,000

11,000

11,000

Original issue discount

5,000

Repayments of notes payable

$ 31,000

LG Capital Funding [Member] | Convertible Note Payable [Member]

Debt Instrument [Line Items]

Principal amount

$ 78,750

Accrued interest

$ 17,044

17,044

Interest rate

8%

Common stock issuable upon conversion

33,408,936

35,015,467

Convertible Notes Payable

$ 48,610

JMJ Financial [Member] | Convertible Note Payable [Member]

Debt Instrument [Line Items]

Principal amount

$ 250,000

Accrued interest

$ 10,564

10,564

Interest rate

10%

Convertible Notes Payable

59,514

Auctus Fund [Member] | Convertible Note Payable [Member]

Debt Instrument [Line Items]

Principal amount

$ 197,000

197,000

197,000

Accrued interest

70,920

70,920

Maturity date

Feb. 07, 2021

Interest rate

12%

Leonite Capital LLC [Member] | Convertible Note Payable [Member]

Debt Instrument [Line Items]

Principal amount

$ 2,285,714

Interest rate

8%

Leonite Capital [Member] | Convertible Note Payable [Member]

Debt Instrument [Line Items]

Principal amount

$ 204,080

$ 2,285,714

Interest rate

8%

Conversion price

$ 0.01

Conversion of stock

20,408,015

Convertible Notes Payable

$ 970,111

GS Capital Partners [Member] | Convertible Note Payable [Member]

Debt Instrument [Line Items]

Principal amount

$ 80,000

$ 53,475

$ 85,000

$ 65,000

$ 172,000

$ 31,229

$ 2,285,714

$ 165,000

Accrued interest

$ 21,633

$ 13,886

$ 23,311

$ 17,278

Maturity date

Aug. 18, 2023

Feb. 20, 2021

Interest rate

10%

8%

10%

Conversion price

$ 0.01

$ 0.01

$ 0.01

$ 0.01

$ 0.01

Conversion of stock

10,163,288

6,736,045

10,831,096

8,277,753

3,122,914

Geneva Roth Remark Holdings [Member] | Convertible Note Payable [Member]

Debt Instrument [Line Items]

Principal amount

$ 251,625

Accrued interest

$ 20,130

Maturity date

Jun. 07, 2022

Interest rate

8%

Original issue discount

$ 22,875

Purchase price

$ 228,750

Sixth Street Lending [Member] | Convertible Note Payable [Member]

Debt Instrument [Line Items]

Principal amount

$ 128,750

$ 103,750

$ 128,750

$ 258,638

Maturity date

Jun. 14, 2023

Feb. 03, 2023

Dec. 10, 2022

Mar. 25, 2023

Interest rate

8%

8%

8%

12%

Gary Shover [Member] | Convertible Note Payable [Member]

Debt Instrument [Line Items]

Principal amount

$ 75,000

75,000

75,000

Accrued interest

$ 3,750

$ 3,750

Maturity date

May 07, 2023

Interest rate

12%

Fourth Man L L C [Member] | Convertible Note Payable [Member]

Debt Instrument [Line Items]

Principal amount

$ 165,000

Interest rate

12%

Original issue discount

$ 16,500

Adar Alef L L C [Member] | Convertible Note Payable [Member]

Debt Instrument [Line Items]

Principal amount

$ 150,000

Interest rate

5%

Ronal Minor [Member] | Convertible Note Payable [Member]

Debt Instrument [Line Items]

Principal amount

$ 25,000

Maturity date

Jun. 14, 2023

Interest rate

12%

Harbor Gates Capital [Member] | Convertible Note Payable [Member]

Debt Instrument [Line Items]

Principal amount

$ 165,000

Maturity date

May 17, 2021

Interest rate

10%

First Fire Global Opportunity [Member] | Convertible Note Payable [Member]

Debt Instrument [Line Items]

Maturity date

Apr. 06, 2021

Feb. 10, 2020

Interest rate

10%

10%

Power Up Lending Group [Member] | Convertible Note Payable [Member]

Debt Instrument [Line Items]

Principal amount

$ 53,000

G H S Investments [Member] | Convertible Note Payable [Member]

Debt Instrument [Line Items]

Principal amount

$ 335,000

Purchaser [Member]

Debt Instrument [Line Items]

Investment return description

Company entered into an Investment Return Purchase Agreement with an accredited investor (the “Purchaser”) for proceeds of $200,000 (the “Investment Agreement”). Under the terms of the Investment Agreement, the Company agreed to pay the Purchaser the $200,000 proceeds plus a 10% return, or $20,000 (the “Investment Return”) within three (3) months from the date of the Investment Agreement. Such Investment Return shall be paid earlier if the Company secures funding totaling $500,000 within 90 days from the date of the Investment Agreement. In addition, the Company agreed to issue to the Purchaser 2,000,000 warrants to purchase common stock of the Company at an exercise price of $0.01 per share, exercisable for a period of three years and expired May 2021. The warrants were valued using the Black Scholes Merton model, resulting in a fair value of $13,000 which were recorded as a discount on the note. The key valuation assumptions used consist, in part, of the price of the Company’s common stock of $0.007 at issuance date; a risk-free interest rate of 2.75% and estimated volatility of the Company’s common stock of 220%. As of December 31, 2022, and through the date of this report, the $200,000 principal and $20,000 Investment Return remained outstanding and is in default.

Accredited Investor [Member]

Debt Instrument [Line Items]

Notes payable

$ 300,000

Original issue discount

150,000

Repayments of notes payable

$ 150,000

STOCKHOLDERS_ EQUITY (Details N

STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	May 09, 2014
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock options vested		4,875,000
Option exercise price	$ 0.60
Average term	3 years 7 months 6 days
Intrinsic value of options outstanding	$ 0	$ 0
Preferred stock, shares authorized	35,000,000	35,000,000	35,000,000
Preferred stock, par or stated value per share	$ 0.001	$ 0.001	$ 0.001
Preferred stock, shares outstanding	1,000,000	1,000,000	1,000,000
Common stock, shares authorized	2,000,000,000	2,000,000,000	2,000,000,000
Common stock, par value	$ 0.001	$ 0.001	$ 0.001
Director [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock options vested	13,650,002	13,650,002
N2014 Global DigitalSolutions Equity Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares reserved for issauance				20,000,000

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Related Party Transaction [Line Items]
Balance at Beginning	$ 141,997	$ 90,834
2022 Salary	75,000	300,000
Payments	(112,184)	(248,837)
Balance at ending	128,334	141,997
William Delgado [Member]
Related Party Transaction [Line Items]
Balance at Beginning	21,163	0
2022 Salary	60,000	240,000
Payments	(81,163)	(218,837)
Balance at ending	(23,521)	21,163
Jerome Gomolski [Member]
Related Party Transaction [Line Items]
Balance at Beginning	120,834	90,834
2022 Salary	15,000	60,000
Payments	(7,500)	(30,000)
Balance at ending	$ 128,334	$ 120,834

RELATED PARTY TRANSACTIONS (D_2

RELATED PARTY TRANSACTIONS (Details 1) - USD ($)	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Related Party Transaction [Line Items]
Compensation owed to related parties	$ 78,690	$ 78,690	$ 57,099
RLTConsulting [Member]
Related Party Transaction [Line Items]
Compensation owed to related parties	21,591	21,591
Jerry Gomolski
Related Party Transaction [Line Items]
Compensation owed to related parties	25,000	25,000	25,000
Charter 804CS [Member]
Related Party Transaction [Line Items]
Compensation owed to related parties	20,099	20,099	20,099
Gary Gray
Related Party Transaction [Line Items]
Compensation owed to related parties	$ 12,000	$ 12,000	$ 12,000

RELATED PARTY TRANSACTIONS (D_3

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	1 Months Ended			3 Months Ended	9 Months Ended	12 Months Ended
	Aug. 31, 2018	Aug. 31, 2017	Aug. 31, 2017	Mar. 31, 2023	Sep. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Jul. 07, 2022	Jun. 14, 2022
Related Party Transaction [Line Items]
Salary				$ 75,000		$ 300,000
Owed balance				78,690		78,690	$ 57,099
Accrued compensation				128,334		141,997	90,834
Employee-related liabilities, current				3,281		3,281	50,000
Advance from related party for operating expenses						$ 140,000
Eco growth repayment						Eco Growth repaid The Company approximately $270,000 in repayment of the current year advances, $140,000, and prior year balance of $80,000. At December 31, 2022, The Company owes Eco Growth approximately $50,000.
William Delgado [Member]
Related Party Transaction [Line Items]
Salary				60,000		$ 240,000
Accrued compensation				(23,521)		21,163	0
Debt amount		$ 20,000	$ 20,000
Interest rate			$ 2,000
Maturity date	Dec. 31, 2021	Aug. 31, 2018	Dec. 31, 2022
Repayments of debt			$ 22,000	22,000		22,000
Employee-related liabilities, current						3,300	50,000
Mr. Delgado [Member]
Related Party Transaction [Line Items]
Accrued compensation						21,000
Advance from related party for operating expenses						9,000
William J Delgado [Member]
Related Party Transaction [Line Items]
Convertible note payment									$ 27,175
Accrued compensation				23,521		21,163	0
Mr. Delgado [Member]
Related Party Transaction [Line Items]
Salary					$ 75,218
Owed balance				3,281				$ 11,957
Eco Growth Strategies Inc [Member]
Related Party Transaction [Line Items]
Due from related party				42,035
Due to related party				8,198
Jerome Gomolski [Member]
Related Party Transaction [Line Items]
Accrued compensation				$ 128,334		$ 120,834	90,834
Mr Delgado [Member]
Related Party Transaction [Line Items]
Repayments of debt							390,000
Reimbursed amount							$ 55,000

SUBSEQUENT EVENT (Details Narra

SUBSEQUENT EVENT (Details Narrative) - USD ($)		1 Months Ended
	Jun. 14, 2022	Apr. 18, 2023	Mar. 31, 2023	Dec. 31, 2022
Subsequent Event [Line Items]
Share Price			$ 0.05	$ 0.0249
Convertible Note Payable [Member] | Leonite Capital [Member]
Subsequent Event [Line Items]
Number of shares converted	20,408,015
Subsequent Event [Member] | Convertible Note Payable [Member] | Leonite Capital [Member]
Subsequent Event [Line Items]
Principal amount converted		$ 139,901
Interest converted		$ 10,198
Share Price		$ 0.01
Number of shares converted		15,000,000

SUMMARY OF SIGNIFICANT ACCOUN_6

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 1) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Related Party Transactions [Abstract]
Warrant Liability balance at beginning of period	$ 1,599,000	$ 606,000	$ 560,000
Additions to warrant liability			(1,736,000)
Change in fair value	$ (851,000)	993,000	1,782,000
Balance at end of period		$ 1,599,000	$ 606,000

STOCKHOLDERS' EQUITY (Details)

STOCKHOLDERS' EQUITY (Details) - $ / shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Weighted Average Number Outstanding	66,446,875	78,346,875
Number Exercisable	66,446,875	78,346,875
Range 1 [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Price	$ 0.01	$ 0.01
Weighted Average Number Outstanding	12,000,000	5,000,000
Outstanding Remaining Contractual Life (in yrs)	4 years	6 months
Weighted Average Exercise Price	$ 0.01	$ 0.004
Number Exercisable	12,000,000	5,000,000
Weighted Average Exercise Price	$ 0.01	$ 0.01
Range 2 [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Price	$ 0.01	$ 0.01
Weighted Average Number Outstanding	1,000,000	3,750,000
Outstanding Remaining Contractual Life (in yrs)	4 years 1 month 6 days	2 years 1 month 6 days
Weighted Average Exercise Price	$ 0.01	$ 0.002
Number Exercisable	1,000,000	3,750,000
Weighted Average Exercise Price	$ 0.01	$ 0.01
Range 3 [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Price	$ 0.01	$ 0.01
Weighted Average Number Outstanding	1,000,000	12,000,000
Outstanding Remaining Contractual Life (in yrs)	4 years 2 months 12 days	2 years
Weighted Average Exercise Price	$ 0.01	$ 0.01
Number Exercisable	1,000,000	12,000,000
Weighted Average Exercise Price	$ 0.01	$ 0.01
Range 4 [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Price	$ 0.01	$ 0.01
Weighted Average Number Outstanding	1,000,000	2,500,000
Outstanding Remaining Contractual Life (in yrs)	4 years 3 months 18 days	2 years 9 months 18 days
Weighted Average Exercise Price	$ 0.01	$ 0.01
Number Exercisable	1,000,000	2,500,000
Weighted Average Exercise Price	$ 0.01	$ 0.01
Range 5 [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Price	$ 0.01	$ 0.01
Weighted Average Number Outstanding	1,000,000	10,000,000
Outstanding Remaining Contractual Life (in yrs)	4 years 4 months 24 days	8 years 2 months 12 days
Weighted Average Exercise Price	$ 0.01	$ 0.01
Number Exercisable	1,000,000	10,000,000
Weighted Average Exercise Price	$ 0.01	$ 0.01
Range 6 [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Price	$ 0.01	$ 0.01
Weighted Average Number Outstanding	1,000,000	20,000,000
Outstanding Remaining Contractual Life (in yrs)	4 years 6 months	8 years 3 months 18 days
Weighted Average Exercise Price	$ 0.01	$ 0.01
Number Exercisable	1,000,000	20,000,000
Weighted Average Exercise Price	$ 0.01	$ 0.01
Range 7 [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Price	$ 0.01	$ 0.01
Weighted Average Number Outstanding	1,000,000	2,096,875
Outstanding Remaining Contractual Life (in yrs)	4 years 7 months 6 days	3 years 7 months 6 days
Weighted Average Exercise Price	$ 0.01	$ 0.01
Number Exercisable	1,000,000	2,096,875
Weighted Average Exercise Price	$ 0.01	$ 0.01
Range 8 [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Price	$ 0.01	$ 0.01
Weighted Average Number Outstanding	1,000,000	12,000,000
Outstanding Remaining Contractual Life (in yrs)	4 years 8 months 12 days	5 years
Weighted Average Exercise Price	$ 0.01	$ 0.01
Number Exercisable	1,000,000	12,000,000
Weighted Average Exercise Price	$ 0.01	$ 0.01
Range 9 [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Price	$ 0.01	$ 0.01
Weighted Average Number Outstanding	1,000,000	1,000,000
Outstanding Remaining Contractual Life (in yrs)	4 years 9 months 18 days	5 years 1 month 6 days
Weighted Average Exercise Price	$ 0.01	$ 0.01
Number Exercisable	1,000,000	1,000,000
Weighted Average Exercise Price	$ 0.01	$ 0.01
Range 10 [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Price	$ 0.01	$ 0.01
Weighted Average Number Outstanding	1,000,000	1,000,000
Outstanding Remaining Contractual Life (in yrs)	4 years 10 months 24 days	5 years 2 months 12 days
Weighted Average Exercise Price	$ 0.01	$ 0.01
Number Exercisable	1,000,000	1,000,000
Weighted Average Exercise Price	$ 0.01	$ 0.01
Range 11 [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Price	$ 0.01	$ 0.01
Weighted Average Number Outstanding	1,000,000	1,000,000
Outstanding Remaining Contractual Life (in yrs)	5 years	5 years 3 months 18 days
Weighted Average Exercise Price	$ 0.01	$ 0.01
Number Exercisable	1,000,000	1,000,000
Weighted Average Exercise Price	$ 0.01	$ 0.01
Range 12 [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Price	$ 0.01	$ 0.01
Weighted Average Number Outstanding	1,000,000	1,000,000
Outstanding Remaining Contractual Life (in yrs)	5 years 1 month 6 days	5 years 4 months 24 days
Weighted Average Exercise Price	$ 0.01	$ 0.01
Number Exercisable	1,000,000	1,000,000
Weighted Average Exercise Price	$ 0.01	$ 0.01
Range 13 [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Price	$ 0.01	$ 0.01
Weighted Average Number Outstanding	10,000,000	1,000,000
Outstanding Remaining Contractual Life (in yrs)	9 years	5 years 6 months
Weighted Average Exercise Price	$ 0.01	$ 0.01
Number Exercisable	10,000,000	1,000,000
Weighted Average Exercise Price	$ 0.01	$ 0.01
Range 14 [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Price	$ 0.01	$ 0.01
Weighted Average Number Outstanding	20,000,000	1,000,000
Outstanding Remaining Contractual Life (in yrs)	8 years	5 years 7 months 6 days
Weighted Average Exercise Price	$ 0.01	$ 0.01
Number Exercisable	20,000,000	1,000,000
Weighted Average Exercise Price	$ 0.01	$ 0.01
Range 15 [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Price	$ 0.03	$ 0.01
Weighted Average Number Outstanding	2,096,875	1,000,000
Outstanding Remaining Contractual Life (in yrs)	1 year	5 years 8 months 12 days
Weighted Average Exercise Price	$ 0.01	$ 0.01
Number Exercisable	2,096,875	1,000,000
Weighted Average Exercise Price	$ 0.01	$ 0.01
Range 16 [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Price	$ 0.01	$ 0.01
Weighted Average Number Outstanding	10,750,000	1,000,000
Outstanding Remaining Contractual Life (in yrs)	4 years 9 months 18 days	5 years 9 months 18 days
Weighted Average Exercise Price	$ 0.01	$ 0.01
Number Exercisable	10,750,000	1,000,000
Weighted Average Exercise Price	$ 0.01	$ 0.01
Range 17 [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Price	$ 0.01	$ 0.01
Weighted Average Number Outstanding	500,000	1,000,000
Outstanding Remaining Contractual Life (in yrs)	3 years	5 years 10 months 24 days
Weighted Average Exercise Price	$ 0.01	$ 0.01
Number Exercisable	500,000	1,000,000
Weighted Average Exercise Price	$ 0.01	$ 0.01
Range 18 [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Price	$ 0.01	$ 0.01
Weighted Average Number Outstanding	100,000	1,000,000
Outstanding Remaining Contractual Life (in yrs)	3 years	5 years 1 month 6 days
Weighted Average Exercise Price	$ 0.01	$ 0.01
Number Exercisable	100,000	1,000,000
Weighted Average Exercise Price	$ 0.01	$ 0.01
Range 19 [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercise Price		$ 0.01
Weighted Average Number Outstanding		1,000,000
Outstanding Remaining Contractual Life (in yrs)		5 years 1 month 6 days
Weighted Average Exercise Price		$ 0.01
Number Exercisable		1,000,000
Weighted Average Exercise Price		$ 0.01

STOCKHOLDERS' EQUITY (Details 1

STOCKHOLDERS' EQUITY (Details 1)	12 Months Ended
	Dec. 31, 2022 shares
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Number of Shares	5,000,000
Vested	4,875,000
Unvested
Forfeited	125,000
Mathew Kelley [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Date of Grant	Apr. 17, 2013
Number of Shares	1,250,000
Vest from	Apr. 30, 2013
Vest To	Mar. 31, 2001
Vested	1,250,000
Unvested
Forfeited
Mathew Kelley 1 [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Date of Grant	Apr. 17, 2013
Number of Shares	1,250,000
Vest from	Feb. 28, 2014
Vest To	Jan. 31, 2015
Vested	1,250,000
Unvested
Forfeited
Richard J Feldman [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Date of Grant	Apr. 30, 2014
Number of Shares	500,000
Vest from	Apr. 30, 2014
Vest To	Mar. 30, 2015
Vested	500,000
Unvested
Forfeited
Richard J Feldman 1 [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Number of Shares	500,000
Vest from	Apr. 30, 2015
Vest To	Mar. 30, 2016
Vested	375,000
Unvested
Forfeited	125,000
Gary Gray
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Date of Grant	Mar. 07, 2015
Number of Shares	1,000,000
Vest from	Mar. 07, 2015
Vest To	May 30, 2015
Vested	1,000,000
Unvested
Forfeited
Ross Trevino [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Date of Grant	Mar. 07, 2015
Number of Shares	500,000
Vest from	Mar. 07, 2015
Vest To	May 30, 2015
Vested	500,000
Unvested
Forfeited

INCOME TAXES (Details)

INCOME TAXES (Details) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Dec. 31, 2021
Related Party Transactions [Abstract]
Net (Income) Loss - book			$ 5,761,061
Loss on disposal of fixed assets			(97,555)
Change in warrant liability			(993,000)
Change in derivative			(2,090,500)
Debt discount amortization	$ (216,386)	$ (482,234)	(1,089,902)	$ (2,303,973)
Estimate loss - tax basis			$ 1,490,104

INCOME TAXES (Details 1)

INCOME TAXES (Details 1) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Related Party Transactions [Abstract]
Income tax expense at statutory federal rate of 21%, Amount	$ 1,210,000
Income tax expense at statutory federal rate of 21%, percent	21%
Impairments, Amount	$ (20,000)
Impairments, percent	0%
Change in warrant liability, Amount	$ (209,000)
Change in warrant liability, percent	(4.00%)
Change in derivative, Amount	$ (439,000)
Change in derivative, percent	8%
Debt discount amortization, Amount	$ (229,000)
Debt discount amortization, percent	(4.00%)
Increase (decrease) in valuation allowance, Amount	$ 313,000
Increase (decrease) in valuation allowance, percent	(21.00%)
Company's effective tax rate, Amount
Company's effective tax rate, Percent	0%

INCOME TAXES (Details 2)

INCOME TAXES (Details 2) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Net Operating Loss Carryforward	$ 22,087,808	$ 21,774,808
NOL tax benefit	4,317,010	4,004,010
Total Deferred Tax Assets	4,317,010	4,004,010
Valuation allowance	(4,317,010)	(4,004,010)
Net Deferred Tax Assets
Activity [Member]
Net Operating Loss Carryforward	313,000
NOL tax benefit	313,000
Total Deferred Tax Assets	313,000
Valuation allowance	(313,000)
Net Deferred Tax Assets

INCOME TAXES (Details Narrative

INCOME TAXES (Details Narrative)	Dec. 31, 2022 USD ($)
Related Party Transactions [Abstract]
Operating loss carry forward	$ 22,087,808
Deferred tax asset and valuation allowance	$ 313,000

SUBSEQUENT EVENTS (Details)

SUBSEQUENT EVENTS (Details) - shares

1 Months Ended

12 Months Ended

Mar. 07, 2023

Mar. 02, 2023

Feb. 08, 2023

Feb. 07, 2023

Feb. 06, 2023

Jun. 30, 2023

Apr. 18, 2023

Mar. 17, 2023

Feb. 23, 2023

Feb. 21, 2023

Jan. 26, 2023

Dec. 31, 2022

Subsequent Event [Line Items]

Shares issued

115,958,182

Share outstanding

798,168,896

Total share issued

914,127,078

Subsequent Event [Member] | Sixth Street Lending [Member]

Subsequent Event [Line Items]

Subsequent event category

Settlemement Agreement

Subsequent event description

The Company entered into a Settlement Agreement on January 26, 2023, with 1800 Diagonal Lending LLC f/k/a Sixth Street Lending LLC, in the amount of $550,000. The settlement agreement was set aside and a Agreed Final Order was issued on ? Pursuant to  the Final order the following note balances and adjustments were made. Initial Notes entered 2/3/2022 with an initial principal amount of $103,750, adjusted to  the sum of $131,096.02, plus interest at the rate of 8% from August 8, 2022, until paid. Note entered  6/14/2022 with a principal amount of $ 202,772.57  adjusted to the sum of $256,218.57, plus interest at the rate of 8 % from August 8, 2022, until paid. Note entered June 14, 2022, with an initial principal of $128,750.00 adjusted to the principal amount of $162,685.42 , plus interest at the of 8 % from August 8,2022 until paid.

Subsequent Event [Member] | Fourth Man L L C [Member]

Subsequent Event [Line Items]

Subsequent event category

Promissory Note

Subsequent event description

On February 6, 2023, The Company and Fourth Man, LLC entered into a Securities purchase agreement for a 12% Convertible Note in the aggregate principal of $165,000.00 less an original issue discount of $16,500.00. The note will mature in 12 months from the issue date. The note in convertible into shares of common stock on the Company at a price of $0.01. The Company shall issue 8,250,000 warrants shares at an exercise price of $0.01 and an exercise period of five years from the issue date.

Subsequent Event [Member] | GS Capital Partners, LLC [Member]

Subsequent Event [Line Items]

Subsequent event category

Notice of Conversion

Notice of Conversion

Notice of Conversion

Notice of Conversion

Subsequent event description

On March 7,2023, GS Capital Partners, LLC. converted $80,000.00 of principal and $21,632.88 of interest for 10,163,288  shares of common stock.

On February 7,2023, GS Capital Partners, LLC. converted $53,474.63 of principal and $13,885.82 of interest for 6,736,045 shares of common stock.

On March 17, 2023, GS Capital Partners, LLC. converted $85,000 of principal and $23,310.96 of interest for 10,831,096, shares of common stock.

On February 23,2023, GS Capital Partners, LLC. converted $65,000.00 of principal and $17,277.53 of interest for 8,277,753 shares of common stock.

Shares issued

10,163,288

6,736,045

10,831,096

8,227,753

Subsequent Event [Member] | Leonite Capital LLC [Member]

Subsequent Event [Line Items]

Subsequent event category

Notice of Conversion

Notice of Conversion

Second Amendment to Senior Secured Convertible Promissory Note

Notice of Conversion

Notice of Conversion

Notice of Conversion

Subsequent event description

On March I, 2023 Leonite Capital LLC converted $200,000 of principal and interest for 20,000,000 shares of common

On February 8, 2023 Leonite Capital LLC converted $100,000 of principal, interest, and fees for 10,000,000 shares of common stock.

Amended June 30, 2023, the Company entered into a second amendment to senior secured convertible promissory note, with  Leonite Capital LLC

On April 18, 2023, Leonite Capital LLC converted $150,000 of principal and interest for 15,000,000 shares of common

On March 17, 2023, Leonite Capital LLC converted $200,000 of principal and interest for 20,000,000 shares of common

On February 21, 2023 Leonite Capital LLC converted $150,000 of principal and interest for 15,000,000 shares of common stock.

Shares issued

20,000,000

10,000,000

15,000,000

20,000,000

15,000,000

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - Subsequent Event [Member] - USD ($)	Jan. 12, 2023	Jan. 04, 2023
Leonite Capital LLC [Member]
Subsequent Event [Line Items]
Debt instrument, interest rate during period		8%
Principal amount		$ 41,666
Original issue discount		$ 4,166
GS Capital Partners, LLC [Member]
Subsequent Event [Line Items]
Debt instrument, interest rate during period	8%
Principal amount	$ 41,667
Maturity date	Jan. 12, 2024
Number of warrant purchase	5,000,000